Esta cúpula abordará os mais recentes desafios comerciais e tecnológicos que afetam o lado da compra em um cenário financeiro e regulatório em constante mudança, bem como estratégias inovadoras para otimizar a execução comercial, gerenciando riscos e aumentando a eficiência operacional, mantendo os custos ao mínimo. WatersTechnology e Sell-Side Technology têm o prazer de apresentar a 7ª Cúpula anual de arquitetura comercial da América do Norte. Reunindo tecnólogos, arquitetos, desenvolvedores de software e gerentes de centros de dados da comunidade financeira para discutir as últimas questões em tecnologia de negociação. Data: 05 de abril de 2017 New York Marriott Marquis, Nova York Cimeira da Tecnologia da Informação Financeira de Tóquio Waters Technology2: 39 p. M. Apogee Enterpr aumenta o dividendo trimestral para 0.14 compartilha de 0.125 compartilhamento (APOG). 2:04 pm Boeing e Jeju Air anunciaram um pedido hoje para três 737-800s da Próxima Geração A ordem, avaliada em quase 300 milhões (BA). A ordem, avaliada em quase 300 milhões a preços de lista atuais, se tornará as companhias aéreas primeiro aviões de compra direta da Boeing e alimentará as companhias aéreas continuando a expansão no mercado de viagens aéreas de rápido crescimento da Asias. O pedido foi previamente atribuído a um cliente não identificado no site Boeings Orders amp Deliveries. 1:18 pm Calendário de ganhos para terça-feira, 10 de janeiro (: SUMRX). Hoje, após o fim de procurar as seguintes empresas para reportar: SNX, LMNRManhã antes do olhar aberto para as seguintes empresas para reportar: SVU, MSM 1:12 pm General Motors na conferência do Deutsche Bank diz que vê o EPS do FY16 no final da orientação prévia O alcance mostra que as expectativas superiores ao EPS do FY17 aprova 5 compras de ações adicionais (GM). Co emite orientação em linha para FY16 (dezembro), vê EPS de alta pontuação de 5.50-6.00 vs. 6.01 Capital IQ Consensus Estimate. Co aborda orientação positiva para FY17 (dezembro), vê EPS de 6.00-6.50 versus 5.70 Capital IQ Consensus Estimate. Com base nesta forte perspectiva, o Conselho de Administração da GM aprovou 5 bilhões adicionais em recompra de ações ordinárias no âmbito do seu programa de recompra de ações existente , Que foi anunciado em 9 de março de 2015. A nova autorização, que não tem data de vencimento, traz o total no programa para 14 bilhões. GM também anunciou um aumento de 1 bilhão em seu objetivo de eficiência de custos, elevando-o para 6,5 bilhões até 2018, Dos quais cerca de 4,0 bilhões já foram alcançados até 2016. O aumento da estimativa baseia-se em economias adicionais esperadas em custos materiais, logísticos, de manufatura e administrativos gerais 1:07 pm Resumo do mercado no meio-dia: médias principais estáveis, bem abaixo das altas da sessão (: WRAPX ): As principais médias ficam logo abaixo das altas da sessão no início desta tarde. O SampP 500 subiu 0,3, enquanto o Nasdaq (0,5) permanece à frente de seus pares. O mercado de ações começou o dia de negociação um pouco menor depois que muitos varejistas e restaurantes emitiram orientação decepcionante. No entanto, as preocupações têm sido encolhidas de ombros pelo mercado, evidenciado pelo aumento de 1,5 em SPDR SampP 500 Retail ETF (XRT 44,46, 0,66). O setor discricionário de consumo também é maior, somando 0,6. Apenas à frente do espaço discricionário do consumidor é o setor financeiro (0.9), que é o topo da tabela de classificação de hoje. Os cuidados de saúde e os industriais seguem de perto, ambos próximos de 0,7. O setor industrial foi auxiliado por um aumento nas companhias aéreas depois que o Alaska Air (ALK 92.33, 4.86) relatou dados de tráfego de dezembro melhores do que o esperado. O Alaska Air é mais alto em 5,5, enquanto a Delta Air Lines (DAL 51,16, 1,46), a Southwest Airlines (LUV 51,59, 1,29), a American Airlines (AAL 48,02, 0,95) e o United Continental (UAL 73,42, 2,15) estão todos entre 2,0 e 3.0. O maior Dow Jones Transportation Average é mais alto em 1.1. O setor de tecnologia ponderada (0,2) se troca um pouco por trás do mercado mais amplo, mas os fabricantes de chips apresentam força relativa. O PHLX Semiconductor Index (0.4) supera ligeiramente, mas o setor mais amplo foi retido por desempenhos sem graça de pesos pesados como Apple (AAPL 119.12, 0.12) e Facebook (FB 62.82, 0.18). A propriedade imobiliária não é contestada no final da classificação de hoje, com uma perda de 1,0. Os pares anticíclicos dos setores - consumíveis e utilitários do consumidor - estão mais próximos de suas linhas planas, mas ainda estão abaixo de 0,3 e 0,2, respectivamente. Os três setores e energia são os únicos espaços negativos do ano. A energia (unch) se agarra à sua linha plana na tentativa de superar o downtick de petróleo bruto 1.0. A commodity negocia perto de sua sessão baixa em 51.43bbl. Para colocar mais pressão sobre o componente de energia, o Índice de Dólar dos Estados Unidos (102.06, 0.14) alcançou território positivo em ação recente depois de passar a manhã no vermelho. Os ganhos ocorrem em fraqueza relativa no euro (1.0557). Os títulos do Tesouro são pouco alterados com o rendimento de 10 anos um ponto base em 2,38. Analisando os dados econômicos de hoje: os estoques de atacado de novembro aumentaram 1,0, o que ficou acima do consenso da Briefing de 0,9. A leitura dos meses anteriores foi revisada para -0,1 de -0,4. O Inquérito de trabalho e o Inquérito ao trabalho de Novembro mostraram que as ofertas de emprego diminuíram para 5,188 milhões de 5,451 milhões (5,534 milhões) em outubro. Para mais informações sobre estes lançamentos econômicos, não se esqueça de visitar o calendário econômico das Reuniões informativas 1:03 pm Tonix Pharma detalha sua Recentemente expandiu o pipeline de produtos na 9ª Conferência Anual Biotech ShOWCASE (TNXP). Co disse, estamos preparados para começar, no primeiro trimestre de 2017, o estudo HONOR da Fase 3 do TNX-102 SL para transtorno de estresse pós-traumático relacionado com militares (PTSD). Estamos confiantes de que podemos reportar o nosso primeiro resultado de linha superior no quarto trimestre de 2017.quot 1:01 pm A Pfizer anuncia um acordo de colaboração de pesquisa com os Termos Financeiros de Pesquisa Scripps, SEM DIVULGADOS (PFE). Nos termos da colaboração, a Pfizer pagará uma taxa de acesso à tecnologia e, assim, obterá acesso a tecnologia de síntese química inovadora desenvolvida na TSRI. Membros do departamento de química da TSRI - Professores Phil Baran, Ph. D. Dale Boger, Ph. D. Jin-Quan Yu, Ph. D. K. Barry Sharpless, Ph. D. E outros - trabalharão ao lado dos cientistas da Pfizer para adaptar esses métodos químicos para serem usados na criação de DELs, que exigem processos rigorosos que sejam tolerantes ao espinha dorsal delicada do DNA. A TSRI e a Pfizer podem optar por expandir o escopo da pesquisa conjunta para incluir outras tecnologias relevantes para permitir a descoberta de medicamentos baseada em DEL. Os termos financeiros do contrato não são divulgados. 1:01 pm A Network-1 anuncia a emissão de patentes da USPTO relacionadas aos seus pedidos de carteira da Cox na patente recém-emitida, geralmente são direcionados para sistemas de identificação de conteúdos e ações de execução seguindo a mesma (NTIP). 12:21 pm Novadaq Tech. LifeNet Healths A matriz dérmica acelular de Dermacell demonstrou melhorias estatisticamente significativas em comparação com o AlloDerm Ready-To-Use de acordo com os resultados DE UM ESTUDO PUBLICADO PELO REVESTIMENTO DE CIRURGIA RECONSTRUCTIVA DE PLÁSTICO DE JORNAL (NVDQ): O ESTUDO RETROSPECTIVO, comparação de diferentes matrizes dérmicas acelulares (ADM) Na Reconstrução mamária: o estudo 50501, comparou resultados clínicos entre Dermacell e AlloDerm RTU na reconstrução mamária - o estudo empírico mais recente para comparar diretamente os dois enxertos. Cinquenta e oito pacientes foram submetidos a procedimentos de reconstrução usando Dermacell (30 pacientes, 50 seios) ou AlloDerm RTU (28 pacientes, 50 seios). O mesmo cirurgião realizou todas as reconstruções. As diferenças na idade média do paciente, Índice de Massa Corporal, porcentagem de pacientes com quimioterapia adjacente neoxi ou irrigação de mama, e número de mastectomias terapêuticas e profiláticas entre os dois grupos de pacientes não foram estatisticamente significantes. As complicações em ambos os grupos foram registradas por 90 dias após a reconstrução. Os autores relataram que, em comparação com o grupo AlloDerm, os pacientes do grupo Dermacell apresentaram melhora estatisticamente significativa na incidência de Síndrome de mama vermelho - com zero casos relatados entre os receptores de Dermacell em comparação com 13 para AlloDerm RTU - e precisava de menos dias antes da remoção do dreno ( 15,8 dias versus 20,6). Além disso, os autores não observaram diferença significativa em termos de seroma, hematoma, cura retardada, infecção, necrose de flap e explicação. Dermacell é processado pela LifeNet Health e distribuído pela NOVADAQ Technologies 12:14 pm Floor Talk: Resilience (: TALKX): Um começo tentativo evoluiu para um avanço mais firme, impulsionado por liderança decente fora do financeiro (0,9), industrial (0,7), setores discricionários do consumidor (0,7) e saúde (0,6). No geral, no entanto, é a resiliência dos mercados aos esforços de venda que continua a atuar como o fator subjacente nos esforços de compra. Alguns casos comercializáveis no ponto hoje incluem o seguinte: O desempenho superior do Russell 2000 (1.0), que apresentou desempenho inferior a segunda-feira com um declínio de 0,7. A força relativa do setor discricionário do consumidor, apesar de uma série de avisos de vendas de vários varejistas especializados. O SPDR SampP Retail ETF (XRT 44.44, 0.62, 1.4) está superando a força relativa dos transportes, que foram demolidos no início de 2017DJTA cresceu 1,2 depois de entrar no mercado de hoje caindo 0,2 em 2017La liderança inicial das finanças em face de um downgrade do Citigroup da Goldman Sachs (GS 242.24, -0.65, -0.3) para vender do Neutral e um downgrade da Goldman Sachs dos viajantes (TRV 117.58, 0.26, 0.2) para vender da Neutral. Bank of America (BAC 22.96, 0.41, 1.8), JPMorgan Chase (JPM 86.56, 0,38 0,4), e Wells Fargo (WFC 54,99, 0,75, 1,4) também estão negociando mais alto em frente aos relatórios de lucros nesta sexta-feira. O setor de energia (0,1) mantendo-se apesar de outra queda nos preços do petróleo (-0,9 a 51,50bbl) T Seu fator de resiliência continua a alimentar o medo de perder os ganhos. Um certo número de participantes provavelmente esperavam uma desvantagem adicional nos saltos das segundas-feiras para o mercado mais amplo, mas quando o seguimento não se materializou em grande medida, ele criou algumas ações que ajudaram a aumentar os principais índices (e Mais em território recorde no caso da Nasdaq). 11:58 am European Markets Closing (: SUMRX). Preços Os mercados europeus estão agora fechados mercados de ações em toda a Europa executados da seguinte forma: UKs FTSE: 0,5 Germanys DAX: 0,2 Frances CAC: 0,0 Spas IBEX: -0,4 Portugals PSI: -1,3 Itália Índice MIB: 0,3 Índice irlandês Ovrl: 0,3 Grécia Índice geral ASE : 0,2 11:41 am Metais básicos, companhias aéreas, prata, varejo, homebuildeRS, BANCOS E TRANSPORTES QUE PRINCIPAIS O MERCADO SUPERIOR COM REÍVEIS, ENERGIA E STAPLES LAGGANDO VS. SPY 0,3 (SPY). XME 3.24 JETS 2.20 SLV 1.85 XRT 1.22 KRE 1.16 ITB 1.19 KBE 1.15 IYT 1.10 IWM 1.04 HACK 1.13XLRE -0.95 OIH -0.55 IYR -0.53 USO -0.53 XLP -0.36 11:41 am Titan Intl apresentará uma breve audiência em janeiro 11 no que diz respeito à sua audição ANTES DE QUE O ITC PERMANECE OPTIMISTICA QUE O ITC ENCONTRARÁ UMA DETERMINAÇÃO FINANCEIRA AFFIRMATIVA NESES CASOS (TWI). 11:08 TENNECO ESTÁ FORNECENDO TECNOLOGIAS DE ÁGUAS LIMPAS NA NOVA família de motores NRM DAIMLER (DDAIF) (TEN). 10:37 am Movedores notáveis de interesse: ILMN 15 como co confirma a introdução da Série NovaSeq (SCANX): Os seguintes são alguns dos principais motores de interesse de hoje, categorizados por capitalização de mercado (grande cap mais de 10 bilhões e tampão médio entre 2 -10 bilhões) e classificado por mudança (todos os estoques acima de 100K de volume médio diário). Large Cap Gainers ILMN (162.85 15.06): Confirma a introdução da NovaSeq Series, uma nova e escalável arquitetura de seqüência esperada um dia para habilitar o lançamento de 100 genomas Illumina e Bio-Rad Laboratories da Solução de Seqüenciamento de célula única Illumina Bio-Rad. ZBH (113.01 5.62): Veja as vendas do quarto trimestre acima do consenso, vê FY16 EPS na parte superior da orientação anterior. CMG (410,04 3,79): as ações negociam mais alto apesar do aviso sobre os ganhos à medida que as vendas melhoraram em meio a comps mais fáceis de grandes capitães perdedores WMB (28,9 -9,49) : Preços de 65 milhões de ações ordinárias em 29 horas. MCO (94,49 -2,45): rebaixado para Neutro de Compra no UBS. Mid Cap Gainers VRX (16.78 9.33): Divests suas marcas CeraVe, AcneFree e AMBI Skincare Para LOreal (LRLCY) por 1.3 bln também para alienar Dendreon por 819.9 mln. MDRX (11.73 8.81): Reafirma a orientação do Q4 e fornece perspectivas iniciais para 2017. W (40.96 7.65): Na Conferência do ICR, o período geral de férias foi bastante forte, pensa que é próximo de um fluxo de caixa livre positivo de forma sustentável. Mid Cap Losers KITE (49,73 -4,35): entra em uma parceria estratégica com Daiichi Sankyo Co para o ciloleucel axicabtageno. ENDP (15.77 -3.9): a reunião do comitê de assessoria do FDA para discutir questões de segurança para a nova droga APLICAÇÃO PARA OPANA ER (OXYMORPHONE HYDROCHLORIDE) COMPRIMIDOS DE LIBERTAÇÃO EXTENSA. 10:02 AM ALLIANCE MMA ADQUIRA SUCKERPUNCH ENTRETENIMENTO DETALHES FINANCEIROS NÃO DIVULGADOS (AMMA). 9:47 am Resumo do mercado de abertura: médias principais Plano aberto (: WRAPX): as principais médias começaram o dia de negociação perto de suas linhas planas com o SampP 500 menor em 0,1. O setor de cuidados de saúde (0,3) está na frente, enquanto os demais grupos não cíclicos ficam abaixo do desempenho. O setor imobiliário, serviços de telecomunicações, utilitários e produtos básicos de consumo estão reduzidos entre 0,3 e 0,7. No lado cíclico, cinco dos seis setores estão em um território positivo. Energia (-0,3) diminui a tendência apesar de um modesto ganho de 0,2 em petróleo bruto. Comércio bruto de WTI a 52.06bbl. Os títulos do Tesouro voltaram para sua linha plana após a PRESSÃO VENDIDA no início. O RENDIMENTO DE 10 YR NÃO ESTÁ INQUÉRITO À 2.37. 9:38 AM A BIOCEPT ANUNCIA QUE GARANTIOU UM ACORDO DE PROVEDOR NA REDE COM BLUE CROSS BLUE SHIELD OF TEXAS TERMOS NÃO DIVULGADOS (BIOC). QuotPartnering com seguradoras de saúde é um foco importante da nossa estratégia de negócios, pois pode aumentar o acesso do médico a esta tecnologia não invasiva para seus pacientes e fornecer adjudicação atempada de pedidos para pacientes. Garantir este acordo na rede é um marco importante para o Biocept, já que o Texas é um dos nossos maiores mercados e o BCBSTX é o maior fornecedor nesse estado. Com este acordo, o número de pacientes com acesso na rede aos nossos testes cresceu para aproximadamente 185 milhões, com alguns membros tendo acesso através de múltiplos planos. As 9:29 am On The Wires (: WIRES). A Xplore Technologies Corp. (XPLR) anunciou que fez parceria com a CLS America para lançar o Thorium X, um sistema de tabelas de comunicações por satélite de primeira classe integrado ao tablet Xplore XSLATE D10 Android robusto. A Xplore recebeu uma ordem inicial do CLS do cliente OEM para 1.000 unidades XSLATE D10 e está preparada para cumprir as ordens de acompanhamento, conforme necessário, nos próximos três anos, para suportar o aumento da produção e as vendas do sistema da marca CLS conforme a demanda do usuário final ditar. A TapImmune, Inc. (TPIV) anunciou a abertura de seu estudo de câncer de ovário patrocinado pela empresa, em Fase 2, em pacientes com câncer de ovário sensíveis à platina. Os primeiros três locais clínicos da empresa receberam a aprovação da Diretoria de Revisão de Investigação (: IRB) para iniciar a inscrição. O estudo utilizará o TPIV 200, uma terapia com células T visando a proteína alfa do receptor de folato. O fornecedor da SPPS (Dexs) anunciou uma parceria que capacita os varejistas a ultrapassar os constrangimentos de soluções de cadeia de suprimentos legais e agilizar a satisfação do varejo digital. Juntos, as empresas oferecem novos recursos que os varejistas precisam atender às demandas de compras elevadas, como o navio da loja e comprar on-line, pegue os TÉCNICOS DE ENCONTRO EM TIENDA NÃO DIVULGADAS. TALLER TECHNOLOGIES (TYL) ANUNCIA UM ACORDO COM O CENTRO DE CONTROLE DO CONDADO DE MONROE EM PENNSYLVANIA PARA TYLERS NOVA SOLUÇÃO DE SEGURANÇA PÚBLICA MUNDIAL DE APLICAÇÃO DE COMPUTADOR (CAD). O acordo inclui implementação de software, treinamento, conversão de arquivos de dados e manutenção 247 CAD de emergência. 9:28 am Simpson Manufacturing adquire visões CG para até 21,5 mln (SSD). O co anunciou que adquiriu recentemente a CG Visions, Inc. uma empresa dos EUA que fornece tecnologia, serviços e consultoria BIM (Building Information Modeling) para a indústria de construção residencial. A aquisição estratégica deverá ajudar a Simpson Strong-Tie a aprofundar suas parcerias com os principais construtores em todo o país, oferecendo soluções de software BIM escaláveis e flexíveis para ajudar os construtores a controlar custos e aumentar a eficiência em todas as etapas do processo de construção de casas. A empresa completou a aquisição por até 21,5 mil milhões de euros, INCLUINDO A RESÍDUOS DE 2.15 MILHÕES SUJEITOS PARA A REUNIÃO DE OBJECTIVOS DE VENDA E SUJEITOS A DISPOSIÇÕES ESPECÍFICAS DE CONDUÇÃO DE FERRAMENTAS E AJUSTES POST-FECHANDO. 9:24 AM BANCOS CENTRAIS DA FLORIDA ANUNCIA PREÇOS DE SUA OFERTA DE STOCK COMUNS DE 2.45 MLN (CSFL). A Co anunciou que vendeu 2.450.000 ações ordinárias para a Keefe, Bruyette amp Woods, A Stifel Company e Raymond James amp Associates, como ARREDORES PARA SUA OFERTA PÚBLICA ANTERIAMENTE ANUNCIADA. A CENTERSTATE PRETENDE UTILIZAR O PRODUTO LÍQUIDO DESTA OFERTA PARA FINS CORPORATIVOS GERAIS. 9:19 JOHN WOOD GROUP PLC GARANTA ACORDO DE QUADRO DE DOLLAR MULTIMILHÃO COM ARAMCO SAUDI (WDGJF). A Co assegurou um acordo-quadro de cinco anos e vários milhões de dólares para continuar a fornecer serviços de engenharia e gerenciamento de projetos aos programas de capital onshore SaudiAramcos no Reino da Arábia Saudita. Com efeito, o contrato também inclui três, extensões de um ano e serão entregues localmente na Arábia Saudita. PRIMEIRO PRÉMIO EM 2010, O SERVIÇO DE ENGENHARIA GERAL, MAIS A EXTENSÃO DO CONTRATO SERÁ ADMINISTRATIVO POR ESCRITÓRIO DE GRUPOS DE MADEIRA EM AL KHOBAR. 9:15 AM A GENIE ENERGY ANUNCIA QUE ESTÁ ESTABELECENDO FORMAÇÃO ATID, UMA VENTURA DE SERVIÇOS DE PERFURAÇÃO ON-SHORE COM BASE EM ISRAEL (GNE). Atid irá perseguir oportunidades de perfuração para clientes em uma variedade de campos, incluindo exploração de petróleo e gás, desenvolvimento de recursos hídricos e exploração mineral. A HAS executou um MOU vinculativo para comprar uma plataforma de perfuração e equipamentos de perfuração associados. A plataforma perfurou com sucesso cinco poços exploratórios de petróleo e gás nos Golan Heights nos últimos dois anos e recentemente completou um poço de água que é orientado para ajudar os agricultores do Golã que estão lidando com uma seca prolongada. Prevê a parceria com serviços internacionais de perfuração Especialistas, incluindo a Rainmaker, uma parceria de prestadores de serviços de perfuração de petróleo e gás da América do Norte, com sede no oeste do Canadá. Espera-se que espúe sua primeira exploração. BEM EM PRIMEIRO MARÇO PARA AFEK PETRÓLEO E GÁS, A SUBVENÇÃO GENIE ENERGÉTICA QUE ESTÁ CONDUZINDO UM ÓLEO E GÁS PROGRAMA EXPLORATÓRIO NAS ALTURAS GOLANAS. 9:13 AM A EUROSEAS ANUNCIA QUE TOMOU A ENTREGA DA ADQUISIÇÃO ANTERIORMENTE ANUNCIADA DE MV TASOS, A 75.100 DWT PANAMAX DRYBULK CARRIER (ESEA). 9:13 am SampP futuros versus valor justo: 0,80. Futuros Nasdaq vs valor justo: 0,40. (: WRAPX): O mercado acionário está no bom caminho para uma abertura plana, uma vez que o mercado de futuros SampP 500 um ponto acima do valor justo. No comércio pré-comercial, o Grill mexicano Chipotle (CMG 412.00, 16.94) é maior em 4.3, apesar de fornecer orientação negativa. Illumina (ILMN 161.53, 19.99) também está acelerando, aumentando 14,1 após a emissão de orientações de receita acima do consenso para o quarto trimestre. Por outro lado, as Williams Companies (WMB 28,62, -3,28) caíram 10,3 depois de avaliar uma oferta secundária. Além disso, o estoque foi rebaixado para Hold from Buy na Jefferies. Depois de um início positivo da semana, os Tesouros dos EUA estão sujeitos a uma modesta pressão de venda no início desta manhã. O rendimento de 10 anos é maior em dois pontos base em 2,39. Os dados econômicos de hoje serão limitados às aberturas de emprego de novembro (: JOLTS) e aos inventários de atacado de novembro (Consenso de informação de 0,9). Ambos os relatórios serão divulgados às 10:00 da manhã do ET. 9:09 am Cargill Q2 adj. O lucro operacional subiu de 80 para 1,03 bilhões, as receitas diminuíram 1 ano (COMDX). O lucro operacional ajustado aumentou 80 para 1,03 bilhões no segundo trimestre, em comparação com 574 milhões no período do ano passado. Para metade, o lucro situou-se em 1,86 bilhões, 57 em relação ao ano passado. Os lucros foram de 26,9 bilhões e 54 bilhões no quarto e meio, respectivamente, cada um abaixo de 1 do último ano. O segmento de Proteção Animal Proteção Animal foi o maior contribuinte para o lucro operacional ajustado no Segundo trimestre, com resultados acima do ano anterior. O grupo de proteínas norte-americanas apresentou forte desempenho em suas linhas de produtos. A remuneração da demanda de férias aumentou as vendas de pássaros inteiros no negócio de peru, enquanto um estoque de gado mais normalizado, produção otimizada e demanda de consumidores saudáveis contribuíram para um Recuperação em carne de bovino nos últimos anos. O negócio de ovos continuou a ver o forte volume de vendas no setor de alimentos. Os segmentos do grupo mundial de aves melhoraram nos últimos anos no segundo trimestre, liderados por bons resultados na Ásia. Os ganhos de processamento aumentaram ligeiramente contra um período comparativo forte, reforçado pelo desempenho no Norte América. Nesses anos, as culturas de milho e soja dos Estados Unidos foram encontradas com Demanda robusta decorrente do crescimento doméstico e internacional na produção pecuária e redução da concorrência sul-americana para exportação. Com o foco da oferta na América do Norte, a Cargill aumentou os volumes em suas origens de grãos e mineração dos EUA e Canadá, instalações de colheita de oleaginosas e exportações, com terminais no Golfo dos EUA e em Vancouver, Colúmbia Britânica, funcionando a capacidade. O Amp. Industrial, os Serviços Financeiros, voltou de um período comparativo fraco, com os ganhos impulsionados pelos resultados comerciais em mercados mais ativos de petróleo bruto e produtos refinados, gás natural e energia elétrica, transporte océano e orageiras da gerência de ativos TAMBÉM CONTRIBUÍDO PARA OS SEGMENTOS MELHORAM O DESEMPENHO. 9:08 AM ATWOOD OCEANICS PREÇOS OFERTA PÚBLICA SUBMARECIDA DE 13.500.000 AÇÕES DE SEU ESTADO COMUM A UM PREÇO AO PÚBLICO DE 12.20SHARE (ATW). A Companhia espera usar o produto líquido da oferta para fins corporativos gerais, que podem incluir o resgate de remessas dentro de sua estrutura de crédito, o financiamento de compras definitivas de suas 6,50 NOTAS DE PRÉMIO DE 2020, CAPITAL DE TRABALHO E DESPESAS DE CAPITAL E DE OUTRO MODO PARA AMBIENTE SUA LIQUIDEZ. 9:04 AM DANA INC ENTRA EM UM MERCADO DE VENDAS COMERCIAL MULTI-ANO COM NAVISTAR INTERNATIONAL CORPORATION (NAV) para componentes de transmissão para veículos rodoviários, de entrega urbana, ônibus e profissionais (DAN). Através deste acordo, a Navistar (NAV) tem acesso a toda a gama de ofertas de produtos de transmissão de corrente Danas. Além disso, a Dana continuará a ser o fornecedor de driveshAFT de posição padrão em todos os modelos de caminhões NAVISTAR. ADEMÁS A ESTE CONTRATO, A NAVISTAR E DANA CONCORDARAM VÁRIOS PACOTES DE GARANTIA EXTENDIDOS PARA A PLATAFORMA DE ÔNIBUS ESCOLAR NAVISTARS E SEU PROGRAMA DURASTAR DE CAMINHÕES MÉDIOS. 9:04 AM CYTOSORBENTS ESPERA PARA REPORTAR O CRESCIMENTO DE VENDAS DUPLICADAS DUPLICADAS DE 8,2 MLN APROVADO NO FY16 VS. THE 9.03 MLN CAPITAL IQ CONSENSUS (CTSO). Co espera reportar cerca de 8,2 mln nas vendas do FY16 (intervalo de 8,1-8,3), dobrando de 4,0 milhões em 2015, em comparação com as vendas de produto de 9.03 mln Capital IQ Consensus. Q4 2016 de aproximadamente 2,6 milhões (faixa de 2,5-2,7M), versus 1,5 milhões no quarto trimestre de 2015, continua seis trimestres consecutivos de vendas recorde, e cresceu sucessivamente em mais de 20 do terceiro trimestre de 2016.2016 as margens brutas de produtos brutos, entre as vendas diretas de margem mais alta e as vendas de distribuidores de menor margem, deverão ultrapassar os 65 superados de 20 mil humanos Tratamentos de CytoSorb versus 9,000 A YEAR AGO. quot. Esses resultados refletem a importância e o impulso contínuos de nossa terapia CytoSorb em hospitais de todo o mundo. À luz de nossas recentes atualizações de parceria e reembolso, acreditamos que estamos bem posicionados para um forte 2017.quot 9:04 am A Qiagen entra em colaboração estratégica com o Singulex focado no desenvolvimento de diagnósticos complementares (QGEN). Através da colaboração, a QIAGEN terá acesso à plataforma de imunodiagnóstico de contagem de moléculas únicas de Singulexs, adicionando CAPACIDADES ADICIONAIS DE IMUNOASSAY PARA PROCURAR SERVIÇOS DE TESTE MOLECULAR EXISTENTES PARA O DESENVOLVIMENTO DE DIAGNÓSTICOS DE COMPANHIA. ADICIONALMENTE, QIAGEN TERÁ ACESSO AO LABORATÓRIO LICENCIADO SINGULEXS CLIA. 9:04 AM COTY PARA ADQUIRIR 60 PERMANECER EM YOUNIQUE PARA APROXIMADAMENTE 600 MLN NA TRANSACÇÃO DE CAIXA ESTÁ ESPERADO SER IMEDIATAMENTE ACRETO AO SEU CRESCIMENTO TOP-LINE, EBITDA MARGEN E FY17 EPS (COTY). O fundador da Youniques e atual CEO, Derek Maxfield, e a Diretora-Chefe, Melanie Huscroft, continuarão a liderar o negócio na nova parceria. Os produtos de maquiagem e pele da Youniques são vendidos através da plataforma de comércio eletrônico peer-to-peer. A Younique espera gerar 400 milhões de dólares na receita líquida em 2016. A Co adquirirá uma participação de 60 partes da Younique por 600 milhões de dólares em dinheiro, que será financiado através de uma combinação de caixa e instalações de débito disponíveis com impacto global na taxa de retenção de COTYS. A TRANSACÇÃO ESTÁ SUJEITA A CONDIÇÕES DE FECHAMENTO CUSTOMÁRIO E É ESPERADO A FECHAR DURANTE O SEU 3T17. A TRANSAÇÃO ESPERA SER IMEDIATAMENTE ACTATIVA PARA SEU CRESCIMENTO TOP-LINE, MARGEM DE EBITDA E RESULTADOS FY17. 9:02 AM SUNRUN AND NATIONAL GRID (NGG) anuncia parceria inclui 100 milhões de participação de capital da National Grid na parceria (RUN). A parceria inclui um acordo de comercialização conjunta, um piloto de serviços de rede colaborativa e um investimento direto da National Grid em sistemas solares Sunrun para o telhado. Sunrun e National Grid também formarão uma parceria para possuir aproximadamente 200 MW de ativos solares residenciais em todos os mercados da Sunruns . A National Grid comprometeu 100 milhões de euros com essa parceria. O investimento destaca a atratividade do setor solar residencial e enfatiza as diversas fontes de capital do SUNRUN PODERÃO SER LEVANTADAS PARA APOIAR O CRESCIMENTO CONTINUADO, INCLUINDO BRIGHTBOXTM, SUNRUNS SOLAR-PLUS-STORAGE SOLUTION. O PRODUTO DO INVESTIMENTO DE GRUPOS NACIONAIS ADICIONÁVEL DE 0,45 A 0,55 POR WATT ADICIONAL AO SUNRUNS ADVANCE TÍPICO TAXAS DE IMPOSTO DE IMPOSTO, ATRIBUIÇÃO DE VOLTAÇÃO E OUTROS PAGAMENTOS PRINCIPAIS. 9:01 AM DANA INC ENTRE EM CONTRATO DE VENDA COMERCIAL MULTI-ANO COM NAVISTAR (NAV) para componentes de transmissão para veículos rodoviários, de entrega urbana, ônibus e profissionais (DAN). Através deste acordo, a Navistar tem acesso a toda a gama de ofertas de produtos de transmissão de corrente Danas. Além disso, a Dana PERMANECERÁ O FORNECEDOR DE DRIVSHAFT STANDARD-POSITION ATRAVÉS DE TODOS OS MODELOS DE CAMINHÕES NAVISTAR. ADEMÁS A ESTE CONTRATO, A NAVISTAR E DANA CONCORDARAM VÁRIOS PACOTES DE GARANTIA EXTENDIDOS PARA A PLATAFORMA DE ÔNIBUS ESCOLAR NAVISTARS E SEU PROGRAMA DURASTAR DE CAMINHÕES MÉDIOS. 9:01 AM CITY OFFICE REIT ANUNCIA O UPSIS E PREÇOS DE SUA OFERTA PÚBLICA SUBRÁRDIDA DE 5.000.000 AÇÕES DE SEU ESTADO COMUM EM UM PREÇO DE OFERTA PÚBLICO DE 12.40SHARE PARA TOTAL DE PRODUTOS BRUTOS DE 62.0 MLN (CIO). A Companhia pretende usar o produto líquido da oferta para a aquisição de imóveis de escritórios, o reembolso de valores pendentes sob a facilidade de crédito garantido e do capital de giro geral, incluindo o financiamento de aquisições e investimentos futuros. 8:59 am On The Wires (: WIRES). A Duke Energy Renewables (DUK) adquiriu três projetos de energia solar da SunPower (SPWR) no total de 55 megawatts. Os sites incluem o Rio Bravo I de 20 MW, o Rio Bravo II de 20 MW e as usinas de energia solar Wildwood Solar II de 15 MW. Eles estão localizados em Kern County, Califórnia, adjacente a dois sites solares existentes de propriedade da Duke Energy Renewables. Verint Systems (VRNT) recebeu um pedido avaliado em mais de 35 milhões para múltiplos componentes de seu portfólio Cyber Intelligence. Espera-se que a implantação demore cerca de dois anos. Dado o cronograma de entrega, este pedido não deverá ter um impacto relevante nos resultados do quarto trimestre de Verints ou na habilidade da Verints de atingir suas orientações anteriormente fornecidas para o ano atual que termina em 31 de janeiro de 2017.FuelCell Energy (FCEL) ANUNCIA A OPERAÇÃO COMERCIAL DE A MEGAWATT-CLASS COMBINED HEAT AND POWER COMBUSTÍVEL PLANTA LOCALIZADA NA SANTA RITA JAIL NO ALAMEDA COUNTY, CALIFORNIA. FORM TECH (FTEK) ANUNCIA A RECEITA DE CONTRATOS MÚLTIPLOS CONTROLE DE CONTROLE DE POLUIÇÃO DE AR DOS CLIENTES NOS EUA. ESTES PRÉMIOS TÊM UM VALOR AGREGADO DE 8:56 AM CAMPING WORLD ANUNCIA PLANOS DE EXPANSÃO EM TEXAS COM A ADQUISIÇÃO DE TERMOS DE NORTE DE TEXAS RV-MAX TERMOS NÃO DIVULGADOS (CWH). A aquisição planejada do RV-Max irá adicionar três novos Supercenters ao Dallas-Ft. Vale a pena o mercado e, como parte de nossos planos de expansão maciça, esperamos anunciar futuros locais do SuperCenter que ofereçam a gama completa de produtos e serviços do Camping World e Good Sam. Adicionados Moody, abraçaremos a filosofia de pessoas, processos e produtos da Marcus como parte de nossa Expansão agressiva, à medida que adicionamos fabricantes e marcas de qualidade, aumentamos nossa presença no mercado e aumentamos a força de trabalho. Cerca de 8:53 am SampP futuros versus valor justo: 0,30. Futuros da Nasdaq versus valor justo: 0,60. (: WRAPX): O mercado de futuros SampP 500. Os índices de patrimônio na região da Ásia-Pacífico encerraram terça-feira em uma nota maioritariamente baixa. O iene avançou contra o dólar na ação noturna, mas esse movimento foi completamente recuperado. Na China, o PPI de dezembro (5,5 anos acima do ano esperado 4,5) aumentou para um máximo de cinco anos, enquanto a inflação no nível de consumo (2,1 anos acima do ano esperado 2,3) foi mais fria do que o esperado. A Comissão Nacional de Desenvolvimento e Reforma disse que a incerteza aumentará em 2017, mas o governo continuará a controlar o desempenho econômico. Em dados econômicos: Chines December PPI 5,5 ano-a-ano (consenso 4.5 último 3.3). CPI de dezembro 0,2 mês a mês (esperado 0,3 último 0,1) 2,1 ano a ano (consenso 2,3 anterior 2,3) Japões dezembro Confiança do lar 43,1 (esperado 41,3 nas últimas 40,9) Australias Novembro Vendas de varejo 0,2 mês sobre o mês (esperado 0,4 Último 0,5) --- Equity Markets --- Japans Nikkei perdeu 0,8 depois de ter sido fechado na segunda-feira. Fast Retailing, Oki Electric, Dai-ichi Life Insurance, Konami, Isuzu Motors, Hino Motors, Credit Saison e NGK Isolados perderam entre 1.8 e 2.6. No lado positivo, a Sony, Tokyo Electron e a Dentsu registraram ganhos entre 1,2 e 2,4. Hong Kongs Hang Seng subiu 0,8 com o apoio da maioria dos componentes. Nomes de propriedade como Sino Land, New World Development, Henderson Land, Cheung Kong Property Holdings e China Resources Land avançaram entre 1,0 e 1,9. Os nomes das telecomunicações ficaram à frente da China Unicom Hong Kong caindo 2,3 e China Mobile derramando 0,3. Chinas Shanghai Composite caiu 0,3. Giti Tire, Shanghai Material Trading, Greattown Holdings e Shanghai Diesel Engine caíram entre 4,4 e 5,8. Indias Sensex avançou 0,7 com nomes sensíveis ao crescimento que lideram o rali. Adani Ports, Tata Motors, Tata Steel e Asian Paints somaram entre 1,5 e 3,3. Os financiamentos foram principalmente mais elevados com o HDFC Bank, o ICIC Bank e o SBI aumentando entre 0,3 e 1,5 enquanto o AXIS Bank perdeu 1,2. Os principais índices europeus trocam com ganhos leves, enquanto Spains IBEX (-0,7) é inferior ao desempenho. Na Alemanha, Jorg Meuthen, economista da direita da AFD, disse que a zona do euro poderia ser dividida em duas divisas separadas - uma mais forte agrupada em torno da Alemanha, enquanto uma mais fraca seria agrupada em torno da França. Lembre-se de que a Marine Le Pen, que se espera que esteja em uma estreita corrida de três vias para a presidência francesa em abril, expressou apoio para mudanças significativas na estrutura da zona do euro. Os dados econômicos foram limitados: Frances November Industrial Production 2,2 mês a mês (esperado 0,6 último -0,1) Taxa de desemprego de dezembro suiça realizada em 3,3, como esperado --- Mercados de ações --- FTSE do Reino Unido é maior em 0,2 com mineros que apresentam parentes força. Anglo American, Rio Tinto, BHP Billiton, Antofagasta e Fresnillo registraram ganhos entre 2,4 e 6,1. Consumer names have also contributed to the advance with Tesco, Morrison Supermarkets, InterContinental Hotels, Merlin Entertainments, Next, and Sainsbury adding between 1.4 and 3.9. Homebuilders Taylor Wimpey, Persimmon, and Barratt Developments are up between 1.7 and 2.7. Germanys DAX has added 0.1. Siemens has jumped 1.7 in reaction to an upgrade, while exporters are mixed. Continental holds a 2.3 gain while Volkswagen sits just below its flat line. Financials have been weak with Commerzbank and Deutsche Bank down 1.4 and 2.7, respectively. Frances CAC sits just above its flat line, looking to avoid its second consecutive decline. Recent strength in commodity prices has sent ArcelorMittal to the top of the days leaderboard with a gain of 3.0. Automakers Renault and Peugeot are up 2.8 anD 0.5, RESPECTIVELY, WHILE FINANCIALS ARE MIXED. SOCIETE GENERALE HAS ADDED 0.4 WHILE CREDIT AGRICOLE AND BNP PARIBAS ARE BOTH DOWN 0.1 AND 0.4, RESPECTIVELY. COUNTERCYCLICAL NAMES LIKE ORANGE AND VEOLIA ENVIRONNEMENT LAG, DOWN 1.6 AND 2.4, RESPECTIVELY. SPAINS IBEX TRADES LOWER BY 0.7 AMID WEAKNESS IN FINANCIALS. BANCO POPULAR, BBVA, BANKIA, BANCO SABADELL, AND CAIXABANK ARE DOWN BETWEEN 0.5 AND 2.8. 8:53 AM COOPER-STANDARD PROVIDES FY17 GUIDANCE IN SLIDE PRESENTATION ( CPS ). Co issues downside guidance for FY17 (Dec), sees FY17 (Dec) revs of 3.48-3.53 bln vs. 3.54 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 12.3-12.8 sees CapEx of 165-175 mln. 8:49 am Gapping down ( SCANX ) : Gapping down In reaction to disappointing earningsguidance: HGG -51.9, (HHGregg sees fiscal Q3 sales of 453 mln vs. 564.3 mln Capital IQ Consensus Est co expects to incur a non-cash charge for asset impairment of 7-12 mln of certain locations in the quarter ended December 31, 2016), ASNA -20.1, WDFC -8.6, FRSH -7.1, (issues downside Q4 revenue guidance), NSTG -6.4, BOOT -5.3, (Boot Barn Holdings reports light prelim Q3 results ahead of ICR conf), SHOO -4.9, CRAY -4.2, (anticipates 2016 revenue to be in previously provided range believes it will be difficult to grow over 2016 in 2017 ), HALO -4.1, (guides 2017 revenue below expectations), SCVL -2.3, (sees FY17 1.36-1.38 vs 1.49 Capital IQ Consensus Estimate sees revs 1.000-1.003 bln vs 1.00 bln Capital IQ Consensus Estimate), ABMD -2.2, (offers prelim Q3 rev results, reaffirms FY17 outlook ahead of presentation at the Annual J. P. Morgan Healthcare Conference), VTR -1.2, HRC -1.1, FLDM -1, ( guides Q4 rev enue below consensus ), Other news: AKER -29 (prices 1,667,000 shares of common stock at 1.20 per share, together with 833,500 five-year warrants to purchase common stock with an exercise price of 1.50)WMB -10.3 (prices 65 mln shares of common stock at 29.00 per share)ATW -5.9 (commenced an underwritten public offering of 13,500,000 shares of common stock)WPZ -4.3 (announce financial repositioning for long-term, sustainable growth Both cos announced an agreement to permanently waive payment obligations), CIO -3.3 (commences 4 mln common stock offering)MACK -1.9 (modestly pulling back following yesterdays strength)DM -1.5 (Dominion Midstream files for offering of 25,383,348 COMMON UNITS REPRESENTING LIMITED PARTNER INTERESTS BY SELLING UNITHOLDERS ), Analyst comments: WRLD -2.3 (downgraded to Underperform from Hold at Jefferies)EXPE -0.9 (initiated with a Sell at Citigroup)GS -0.8 (downgraded to Sell at CitigrouP) 8:47 AM HILL INTERNATIONAL RECEIVES A FIVE-YEAR CONTRACT WORTH APPROX. 35 MLN FROM THE SANTA CLARA VALLEY TRANSPORTATION AUTHORITY ( HIL ). Hill international will provide project management oversight and construction management services in connection with Valley Transportation Authoritys highway, roadway, pedestrianbicycle, transit and facility projects. 8:46 am Coherus BioSciences announces positive topline 24-week treatment phase 3 results for CHS-1420 in patients with psoriasis ( CHRS ) : This is a confirmatory 3-part study in patients with active, moderate to severe, chronic plaque psoriasis. Data from this study will be presented at an upcoming scientific conference. They currently anticipate filing the Biologic License Application submission in the first half of 2017. As previously reported, this study met its primary endpoint demonstrating similarity between CHS-1420 and Humira with respect to percentage of subjects achieving 75 improvement in psoriasis area and severity index at week 12. The 95 confidence intervals for the difference between treatment groups fell well within the pre-specified margin. Results from Part 2 of the study focused on maintenance of response through Week 24. At the start of Part 2, 80.3 of subjects in the CHS-1420 group and 77.5 of subjects in the Humira group achieved PASI-75. In Part 2, half of the subjects who were initially treatED WITH HUMIRA WERE SWITCHED TO CHS-1420, MODELING A CHRONIC PATIENTS TRANSITION TO A BIOSIMILAR. IN PART 2, MAINTENANCE OF PASI-75 WAS SIMILAR ACROSS THE 3 SUBSEQUENT TREATMENT GROUPS: CHS-1420 FOLLOWED BY CHS-1420, HUMIRA FOLLOWED BY CHS-1420, AND HUMIRA FOLLOWED BY HUMIRA. CHS-1420 AND HUMIRA WERE SIMILARLY WELL TOLERATED IN ALL GROUPS DURING PART 2. ANTI-DRUG ANTIBODY RESULTS ARE PRELIMINARY AT THIS TIME, BUT HAVE NOT IDENTIFIED ANY CLINICALLY SIGNIFICANT DIFFERENCES BETWEEN THE TREATMENT GROUPS. 8:45 AM KOPPERS HOLDINGS REPEATS FY16 GUIDANCE IN SLIDE PRESENTATION ( KOP ). Co repeats guidance for FY16 (Dec), sees FY16 (Dec) revs of 1.4 bln vs. 1.41 bln Capital IQ Consensus Estimate sees FY16 consolidated EBITDA of 168-172 mln. 8:45 am Gapping up ( SCANX ) : Gapping up In reaction to strong earningsguidance: PXLW 12.4, (sees Q4 revs at high end of guidance, expects to report GAAP profitability ) CUDA 8.5, MDRX 6.7, (ticking hiGHER REAFFIRMS Q4 GUIDANCE AND PROVIDES INITIAL OUTLOOK FOR 2017 ), ZBH 3.8, CMG 2.5, EXPR 1.8, OFIX 1.8, TACO 1.7, (PREANNOUNCES Q4 SALES WITH COMPS 5.5, JUST ABOVE ESTIMATES), VOXX 0.9, ZLTQ 0.7, (DISCLOSES COMMERCIAL LEADERSHIP TRANSITION, PROVIDES PRELIM Q4 RESULTS, FY17 GUIDANCE), MampA news: VRX 11.7 (divests its CeraVe, AcneFree and AMBI Skincare brands To LOreal ( LRLCY ) for 1.3 bln also to divest Dendreon for 819.9 mln ) Select metalsmining stocks trading higher: RIO 5.1, VALE 4.7, BBL 4.7, CLF 4.6, MT 4.4, FCX 4.1, X 2.9, AKS 2.3 Other news: NGNVC 44.5 (continued strength extending late surge higher yesterday), XGTI 20 (regains full compliance with all listing requirements of the Nasdaq), ILMN 14 (confirms the introduction the NovaSeq Series, a new and scalable sequencing arch itecture expected one day to enable a 100 genome Illumina and Bio-Rad Laboratories launch of the Illumina Bio-Rad Single-Cell Sequencing Solution), ARRY 8.1 (still checking), PTX 6.3 (continued strength), SSI 5.7 (modestly rebounding), KITE 3.5 (KITE PHARMA ENTERS INTO A STRATEGIC PARTNERSHIP WITH DAIICHI SANKYO CO FOR AXICABTAGENE CILOLEUCEL) PSTI 3.4 (ANNOUNCED THAT ITS PHASE III STUDY OF ITS PLX-PAD CELLS IN THE TREATMENT OF CRITICAL LIMB ISCHEMIA WAS CLEARED BY THE FDA EXPECTS TO BEGIN ENROLLING PATIENTS IN ITS PHASE III STUDY IN BOTH THE U. S. AND EUROPE DURING 1H17), BIO 3 (ILLUMINA AND BIO-RAD LABORATORIES LAUNCH OF THE ILLUMINA BIO-RAD SINGLE-CELL SEQUENCING SOLUTION), PBR 2.8 (PRICES 4 BLN IN GLOBAL NOTES), CNDT 2.4 (HIGHER IN AFTER HOURS AFTER CARL ICAHN AFFIRMED 9.77 ACTIVE STAKE IN THE XEROX ( XRX ) spin-off ), ZIOP 2.4 (ZIOPHARM amp Intrexon ( XON ) announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T cells targeting neoantigens), FEYE 1.7 (in sympathy with CUDA), CYBR 1.1 (IN SYMPATHY WITH CUDA), Analyst comments: TIME 2.7 (upgraded to Outperform from Market Perform at Wells Fargo), ETFC 1.8 (upgraded to Buy from Neutral at Goldman ), VOD 1.7 (upgraded to Buy from Neutral at Goldman ), XRX 1.6 (upgraded to Buy from Neutral at Goldman ), BIDU 1 (upgraded to Buy from Hold at Stifel) 8:39 am EXFO amends Annual Report for fiscal 2016 after identifying a material weakness in the companys internal control over financial reporting ( EXFO ) : Subsequent to the original filing of its Annual Report on Form 20-F for fiscal 2016 on November 28, 2016, EXFO management identified a material weakness in the companys internal control over financial reporting, resulting in the improper aging of its trade accounts receivable ledger which led to an incorrect assessment of bad debt expense against a single trade account receivable. Specifically, the company did not maintain sufficient controls over the trade accounts receivable ledger, which included failure to maintain appropriate segregation of duties as well as lack of supervisory review and monitoring of journal entries recorded to the trade accounts receivable ledger. EXFO management determined that the identified control deficiencies could have resulted in a material misstatement of the aforementioned account balances or disclosures that would not have been prevented or detected, and therefore these control deficiencies represent a material weakness in internal control over financial reporting. Considering the identified material weakness, the companys Chief Executive Officer and the Chief Financial Officer have concluded that internal controls over financial reporting were not effective as of August 31, 2016.Although EXFO management determined that the errors were not material to the previously issued consolidated financial statements and disclosures in its Annual Report on Form 20-F for the year ended August 31, 2016, management revised its previously issued consolidated financial statements to reflect the correction oF THE BAD DEBT EXPENSES IN THE PROPER PERIODS. THE REVISIONS DO NOT CONSTITUTE A RESTATEMENT OF PRIOR YEARS FINANCIAL STATEMENTS. THE IMPACT OF THE REVISION ON EXFOS CONSOLIDATED FINANCIAL STATEMENTS AS AT AND FOR THE YEAR ENDED AUGUST 31, 2016 ARE NON-CASH AND THEREFORE DO NOT AFFECT THE COMPANYS STATEMENTS OF CASH FLOWS FOR ANY OF THE PRIOR PERIODS AND DO NOT AFFECT THE COMPANYS CONSOLIDATED STATEMENTS OF EARNINGS FOR THE YEAR ENDED AUGUST 31, 2016. THE IMPACT ON NET EARNINGS AMOUNT TO A REDUCTION OF US441,000 AND US527,000 FOR THE FISCAL YEARS ENDED AUGUST 31, 2015 AND 2014, RESPECTIVELY. 8:38 AM LEAR PROVIDES FY17 GUIDANCE IN SLIDE PRESENTATION ( LEA ). Co issues upside guidance for FY17 (Dec), sees FY17 (Dec) revs of 19.5 bln vs. 19.26 bln Capital IQ Consensus Estimate sees core operating earnings of 1.6 billion sees FY17 total vehicle unit production of 91.7 mln vs 90.9 mln in FY16 8:38 am EP Energy files for 43,786,694 common stock offering by selling stockholders ( EPE ). 8:34 am Lamb Weston beats by 0.07, beats on revs guides FY17 EPS above consensus, raises sales outlook ( LW ). Reports Q2 (Nov) earnings of 0.63 per share, excluding non-recurring items, 0.07 better than the Capital IQ Consensus of 0.56 revenues rose 6.8 yearyear to 790.7 mln vs the 772.1 mln two analyst estimate. Volume increased 4 percentage points as productivity programs and strong manufacturing plant performance stretched available capacity, allowing the Company to meet demand growth in both North America and international markets. Pricemix increased 3 percentage points due to pricing actions and favorable product and customer mix. CO ISSUES upside guidance for FY17, sees EPS of 2.20-2.28, excluding non-recurring items, vs. 2.11 Capital IQ Consensus Estimate sees net sales up mid-single digits vs. prior guidance for up low single digits. Co expects Adjusted EBITDA including unconsolidated joint ventures to grow at a mid-teens rate, up from a previous estimate of a high single digit increase, reflecting solid sales growth and savings from supply chain efficiencies, partially offset by lower contribution from equity method investment earnings. Potato costs are expected to remain essentially flat. 8:33 am Dexcom sees Q4 revs roughly in line with estimates sees FY17 revs below consensus ( DXCM ). Co issues in-line guidance for Q4 (Dec), sees Q4 (Dec) revs of 168 mln vs. 167.15 mln Capital IQ Consensus Estimate. quot2016 was a RECORD YEAR FOR DEXCOM. WE ESTIMATE THAT 80,000 TO 90,000 NEW PATIENTS ADOPTED DEXCOM CONTINUOUS GLUCOSE MONITORING WORLDWIDE AND WE ENDED THE YEAR WITH APPROXIMATELY 200,000 PATIENTS GLOBALLY, UP FROM APPROXIMATELY 140,000 AT THE END OF 2015.quotCo issues downside guidance for FY17 (Dec), sees FY17 (Dec) revs of 710-740 mln vs. 750.92 mln Capital IQ Consensus Estimate. At the end of 2017, the company is targeting a patient base of 270,000 worldwide and continues to estimate that patients outside of the United States will be approximately 20 to 25 of its global patient base. 8:33 am Sarepta Therapeutics discloses entry into two agreements with the Nationwide Childrens Hospital ( SRPT ). The co has entered an exclusive license agreement with Nationwide Childrens Hospital, for their Galgt2 gene therapy program developed by researcher Dr. Paul Martin, Ph. D. The experimental program explores the potential surrogate gene therapy approach to Duchenne muscular dystrophy. quotOur goal is to have this program in the clinic during 2017 and begin to evaluate a therapy that has the potential to treat patients of all ages and disease severity. quotThe co also has entered a research and option agreement with Nationwide Childrens Hospital on their microdystrophin gene therapy program. Dr. Jerry Mendell, M. D. and Dr. Louise Rodino-Klapac, Ph. D. are the lead principal investigators of thE PROGRAM. THE INITIAL TRIAL, EXPECTED TO GO INTO PHASE 12A TRIAL IN LATE 2017, WILL BE CONDUCTED AT NATIONWIDE CHILDRENS. PARENT PROJECT MUSCULAR DYSTROPHY HAS COMMITTED 2.2 MILLION DOLLARS TO THE TRIAL, WITH SUPPORT FROM ADDITIONAL DUCHENNE FOUNDATIONS AND FAMILIES. SAREPTA HAS COMMITTED TO THE TRIAL THROUGH A SEPARATE RESEARCH AGREEMENT WITH NATIONWIDE CHILDRENS, AND HAS AN EXCLUSIVE OPTION TO LICENSE THE PROGRAM. PPMDS GRANT PROVIDED INCENTIVE FOR SAREPTA TO HELP EXPAND AND ACCELERATE THIS OPPORTUNITY. 8:33 AM CORVUS PHARMACEUTICALS ANNOUNCES THAT THE PROTOCOL-PREDEFINED CRITERIA FOR EXPANSION HAS BEEN REACHED FOR THE COHORT OF PATIENTS WITH RENAL CELL CARCINOMA TREATED WITH SINGLE-AGENT CPI-444 IN THE COMPANYS ONGOING PHASE 11B STUDY ( CRVS ). Co announced that the protocol-predefined criteria for expansion has been reached for the cohort of patients with renal cell carcinoma treated with single-agent CPI-444 in the Companys ongoing Phase 11b study. The size of that cohort will be increased from 14 to 26 patients. The Phase 11b study is evaluating CPI-444, a selective and potent inhibitor of the adenosine A2A receptor, as a single agent and in combination with Genentechs Tecentriq (atezolizumab).The first part of the trial (dose-selection) was completed in October 2016, and enrollment of patients in disease-specific cohorts in the second part of the trial is currently underway. Could potentially initiate a registration trial before the end of 2017. That study would evaluate CPI-444 in late-stage renal cancer patienTS, FOR WHOM CURRENT TREATMENT OPTIONS ARE VERY LIMITED. TO DATE, CPI-444 HAS BEEN WELL TOLERATED WHEN GIVEN ORALLY TWICE DAILY. HAS ALSO SEEN PROMISING EVIDENCE OF SINGLE-AGENT ACTIVITY IN PATIENTS IN OTHER DISEASE-SPECIFIC COHORTS, INCLUDING LUNG CANCER AND MELANOMA. THE PRIMARY ENDPOINTS OF THE STUDY ARE RESPONSE RATE AND DURATION OF CLINICAL BENEFIT. BASED ON BIOMARKER ANALYSES SHOWING SUSTAINED, COMPLETE BLOCKADE OF THE ADENOSINE A2A RECEPTOR IN PERIPHERAL BLOOD LYMPHOCYTES, AND EVIDENCE OF IMMUNE ACTIVATION IN CIRCULATING LYMPHOCYTES, AN OPTIMUM SINGLE AGENT AND COMBINATION DOSE OF 100 MG TWICE A DAY FOR 28 DAYS WAS SELECTED FOR THE SECOND PART OF THE STUDY. 8:32 AM RED ROBIN GOURMET FOLLOW UP - CO ISSUES DOWNSIDE GUIDANCE AHEAD OF ICR CONFERENCE ( RRGB ). Co issues downside guidance for Q4 (Dec), sees Q4 (Dec) revs of 290.80 mln vs. 299.52 mln Capital IQ Consensus EstimatePARABLE RESTAURANT REVENUE DECREASE OF 4.5 COMPARABLE GUEST COUNT DECREASE OF 2.9 quotThe initiatives we put in place last fall -- our new 6.99 every day value items, improved SPEED TO TABLE, AND THE LETS BURGER AD CAMPAIGN -- ARE HELPING US GROW MARKET SHARE AGAIN, quot said DENNY MARIE POST, RED ROBIN GOURMET BURGERS, INC. S CHIEF EXECUTIVE OFFICER. quotWe outperformed casual dining industry traffic trends by 243 basis points in Q4 and saw further improvement in guest service ratings. Continuing this momentum and layering in off-premise initiatives later this year will help us grow in 2017 and beyond. quot 8:31 am Resonant CEO Terry Lingren will retire George B. Holmes, the cos President and Chief Commercial Officer, has been named his successor effective immediately ( RESN ). 8:31 am Mellanox Tech announces that Spectrum Ethernet switches amp ConnectX 4 100Gbs Ethernet adapters have been selected by Baidu ( BIDU ) for Baidus Machine Learning platforms terms not disclosed ( MLNX ). 8:31 am SampP futures vs fair value: flat. Nasdaq futures vs fair value: 0.40. (:WRAPX) : The stock market is poised for a flat open as the SampP 500 futures trade at fair value. In corporate news, many companies have issued guidance ahead of conferences today. Several retailers and restaurants have issued cautious guidance, including Chipotle Mexican Grill (CMG 396.00, 0.94), Papa Murphys (FRSH 4.25, 0.00), POPEYES LOUISIANA KITCHEN (PLKI 59.06, 0.00), KONA GRILL (KONA 11.75, 0.00), SHOE CARNIVAL (SCVL 25.49, 0.00), BOOT BARN HOLDINGS (BOOT 11.50, -0.64), AND EXPRESS (EXPR 10.50, 0.19), AMONG OTHERS. ON THE EARNINGS FRONT, BARRACUDA NETWORKS (CUDA 25.80, 2.03) IS HIGHER BY 8.5 IN PRE-MARKET TRADE AFTER BEATING TOP AND BOTTOM LINE ESTIMATES AND ISSUING IN-LINE GUIDANCE. WD-40 (WDFC 110.30, -7.00) IS LOWER BY 6.0 AFTER MISSING ON THE TOP AND BOTTOM LINES AND REAFFIRMING GUIDANCE. U. S. TREASURIES REMAIN UNDER PRESSURE WITH THE 10-YR YIELD UP TWO BASIS POINTS TO 2.39. 8:30 AM LABORATORY CORP TO ACQUIRE ASSETS OF MOUNT SINAI HEALTH SYSTEM CLINICAL OUTREACH LABORATORIES TERMS NOT DISCLOSED ( LH ). Mount Sinai will continue to provide laboratory testing for patients registered at its hospitals and ambulatory facilities as inpatients or outpatients, as well as laboratory testing services for physiCIANS IN THEIR PROFESSIONAL PRACTICES IN THE AREAS OF ANATOMIC PATHOLOGY, MOLECULAR PATHOLOGY AND GENETICS. LABCORP WILL OFFER CLINICAL PATHOLOGY TESTING, INCLUDING CYTOLOGY AND CYTOLOGY-RELATED MOLECULAR TESTING. SEVEN PATIENT SERVICE CENTERS CURRENTLY OPERATED BY MOUNT SINAI WILL BE ADDED TO LABCORPS EXISTING NETWORK OF 120 PATIENT SERVICE CENTERS IN THE METROPOLITAN NEW YORK CITY AREA. THE PARTIES ARE ALSO VIGOROUSLY EXPLORING OPPORTUNITIES TO COLLABORATE ON PROJECTS INVOLVING COMPANION DIAGNOSTICS, CLINICAL TRIALS AND MEDICAL EDUCATION. THE TRANSACTION, WHICH HAS ALREADY RECEIVED CLEARANCE UNDER THE HART-SCOTT-RODINO ANTITRUST IMPROVEMENTS ACT OF 1976, IS EXPECTED TO CLOSE IN THE FIRST QUARTER OF 2017 8:30 AM PERRIGO TO CHANGE REPORTING SEGMENTS BEGINNING IN Q4 - WILL HAVE NO IMPACT ON HISTORICAL RESULTS ( PRGO ) : Co changes its reporting segments to better align with its organizational structure. Beginning with the Q4, its new reporting segments are: Consumer Healthcare Americas -- Comprises the legacy US, Mexico and Canada consumer healthcare business (OTC, contract, infant formula and animal health categories). Consumer Healthcare International -- Comprises the legacy Branded Consumer Healthcare segment and now includes its consumer focused businesses in the UK Australia and Israel, which were previously reported in the legacy Consumer Healthcare segment. Prescription Pharmaceuticals -- Comprises the legacy US Prescription Pharmaceuticals business. Specialty Sciences -- Will continue to comprise royalties from Tysabri. Other -- Will continue to comprise the legacy Active Pharmaceutical Ingredients (:API) business. 8:29 am On The Wires (:WIRES). Lianluo Smart Limited (LLIT) announced that it has received the design patent certificate for the DHR 998 Plus Wearable Sleep Apnea Syndrome Diagnostic Watch, which is a main product under the business of the Companys medical wearable device sector. Natera (NTRA) announced the termination of a distribution agreement with Bioreference Laboratories. With the ending of the distribution agreement, Natera intends to promote Panorama directly to clinicians, who previously ordered this test through Bio-Reference. Natera also plans to promote its Horizon carrier screen test to these clinicians, which it had not done previously. Lionsgate (LGF. A, LGF. B) announced that it has invested in leading eSports franchise Immortals. Merck (MKGAY) announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise. Majesco Entertainment (COOL) changes name to PolarityTE, Inc. effective January 11 ticker unchanged. Wix (WIX) announced its integration with Square to give Wix merchants and entrepreneurs in North America a new way to accept online and in-person credit card payments. RedHill Biopharma (RDHL) announced the first group of subjects have been dosed in a single-dose three-way crossover pharmacokinetic study with RHB-105 versus the active comparators in the confirmatory Phase III STUDY AND IN A FOOD-EFFECT STUDY WITH RHB-105 IN HEALTHY VOLUNTEERS. THE CONFIRMATORY PHASE III STUDY WITH RHB-105 FOR H. PYLORI INFECTION IS PLANNED TO BE INITIATED, SUBJECT TO REGULATORY APPROVALS AND COMPLETION OF THE SUPPORTIVE PHARMACOKINETIC PROGRAM, BY APRIL OF THIS YEAR. SUBJECT TO A SUCCESSFUL OUTCOME, THE CONFIRMATORY PHASE III STUDY AND THE SUPPORTIVE PHARMACOKINETIC PROGRAM ARE EXPECTED TO COMPLETE THE PACKAGE REQUIRED FOR A U. S. NDA FOR RHB-105.INVIVO THERAPEUTICS (NVIV) ANNOUNCED THAT RHODE ISLAND HOSPITAL IN PROVIDENCE, RI HAS BEEN ADDED AS A CLINICAL SITE FOR THE INSPIRE STUDY: INVIVO STUDY OF PROBABLE BENEFIT OF THE NEURO-SPINAL SCAFFOLD FOR SAFETY AND NEUROLOGIC RECOVERY IN SUBJECTS WITH COMPLETE THORACIC AIS A SPINAL CORD INJURY. 8:22 AM VARIAN MEDICAL BOARD APPROVES SEPARATION OF THE COMPANYS IMAGING COMPONENTS BUSINESS ( VAR ) : The separation is intended to be executed via a tax-free distribution to Varian stockholders of common stock in Varex Imaging Corporation, a new stand-alone public company that will hold the Imaging Components business. The distribution is expected to be completed ON JANUARY 28, 2017, SUBJECT TO THE SATISFACTION OR WAIVER OF THE CONDITIONS TO THE COMPLETION OF THE DISTRIBUTION DESCRIBED IN THE PRELIMINARY INFORMATION STATEMENT FILED AS AN EXHIBIT TO VAREXS REGISTRATION STATEMENT ON FORM 10 FILED WITH THE U. S. SECURITIES AND EXCHANGE COMMISSION. IN THE DISTRIBUTION, VARIAN STOCKHOLDERS WOULD RECEIVE 0.4 SHARE OF VAREX COMMON STOCK FOR EVERY ONE SHARE OF VARIAN COMMON STOCK HELD AS OF JANUARY 20, 2017, THE RECORD DATE FOR THE DISTRIBUTION. NO FRACTIONAL SHARES OF VAREX WILL BE ISSUED. VAREX SHARES ARE EXPECTED TO BEGIN quotregular wayquot trading on Monday, January 30, 2017 on Nasdaq under the ticker symbol quotVREXquot. Varian will continue to trade on the New York Stock Exchange under the ticker symbol quotVARquot. 8:19 am Novo Nordisk announces the EC granted marketing authorization for Fiasp for the treatment of diabetes in adults ( NVO ). The co expects to launch Fiasp in the first European countries in the first half of 2017. 8:16 am Icahn Enterprises commences 900 mln private placement of Senior Notes due 2022 and Senior Notes due 2024 and, separately, announces 600 mln rights offering ( IEP ). The proceeds from the Notes offering, together with cash and cash equivalents at Icahn Enterprises and cash received from redemptions from investment funds, will be used to redeem all of the Issuers existing 3.500 Senior Notes due 2017 and pay related fees and expenses. The purposes of the rights offering are: (i) to enhance IcahN ENTERPRISES DEPOSITARY UNIT HOLDER EQUITY (II) TO ENDEAVOR TO IMPROVE ICAHN ENTERPRISES CREDIT RATINGS AND (III) TO RAISE EQUITY CAPITAL TO BE USED FOR GENERAL PARTNERSHIP PURPOSES. PURSUANT TO THE RIGHTS OFFERING, ICAHN ENTERPRISES WILL DISTRIBUTE FREELY-TRADABLE RIGHTS PRO RATA TO HOLDERS OF RECORD OF ICAHN ENTERPRISES DEPOSITARY UNITS AS OF THE CLOSE OF BUSINESS ON THE RECORD DATE TO BE ESTABLISHED FOR THE RIGHTS OFFERING. CARL C. ICAHN, WHO BENEFICIALLY OWNS 89.89 OF THE COMPANYS OUTSTANDING DEPOSITARY UNITS, HAS INFORMED THE COMPANY THAT CERTAIN OF HIS AFFILIATES INTEND TO EXERCISE FULLY ALL BASIC SUBSCRIPTION RIGHTS AND OVER-SUBSCRIPTION RIGHTS ALLOCATED TO THEM IN THE RIGHTS OFFERING. 8:13 AM NATERA TERMINATES A DISTRIBUTION AGREEMENT WITH BIO-REFERENCE LABORATORIES INTENDS TO PROMOTE PANORAMA DIRECTLY TO CLINICIANS, WHO PREVIOUSLY ORDERED THIS TEST THROUGH BIO-REFERENCE ( NTRA ). Co also plans to promote its Horizon carrier screen test to these clinicians, which it had not done previously. 8:11 am CAS Medical offers prelim Q4 revs results, discusses FY17 outlook ( CASM ) : Co sees Q4 revs 5.5 mln vs 5.59 mln two analyst estimate. A record 82 FORE-SIGHT cerebral oximeters were shipped in the fourth quarter to new and existing customers in the U. S. Net of returns, 45 monitors were shipped in the U. S. bringing the installed base of U. S. monitors to 1,120 units as of December 31, 2016, up from 914 monitors as of December 31, 2015. Net 43 monitors were shipped to international customers in the fourth quarter. quotOur expectations for 2017 include a 20 increase in disposable FORE-SIGHT sensor sales and a 20 increase in the U. S. monitor installed base, coming from gains in market share and from market expansion for cerebral oximetry monitoring. We expect growth to accelerate in the second half of 2017, driven by the expansion and maturation of our U. S. salesforce. We expect total FORE-SIGHT sales growth for 2017 in the mid-teens. quot 8:08 am SampP futures vs fair value: 1.00. Nasdaq futures vs fair value: 2.30. (:WRAPX) : Equity futures are flat ahead of Tuesdays open with the SampP 500 futures trading one point above fair value. Global markets are mixed with Asia closing on a mostly lower note while European indices hold modest gains. Crude oil spent most of the overnight session near its flat line and remains at the same level this morning. The commodity is modestly higher, up 0.3 at 52.11bbl. After an upbeat start to the week, U. S. Treasuries are under modest selling pressure early this morning. The 10-yr yield is higher by two basis points at 2.39. Todays economic data will be limited to November Job Openings (:JOLTS) and November Wholesale Inventories (Briefing consensus 0.9). Both reports will be released at 10:00 am ET. In U. S. corporate news of note: Chipotle Mexican Grill (CMG 382.00, -13.06): -3.3 after issuing downside guidance. Barracuda Networks (CUDA 26.00, 2.23): 9.8 after beating on revenues and issuing in-line guidance. Williams Companies (WMB 28.83, -3.10): -9.7 after the stock was downgraded to Hold from Buy at Jefferies. Illumina (ILMN 161.00, 19.46): 13.8 after issuing above-consensus revenue guidance for the fourth quarter. The stock was upgraded to Buy from Neutral at Bank of AmericaMerrill Lynch. Reviewing overnight developments: Equity indices in the Asia-Pacific region ended Tuesday on a mostly lower note. Japans Nikkei -0.8, Hong Kongs Hang Seng 0.8, Chinas Shanghai Composite -0.3, Indias Sensex 0.7.In economic data: Chinas December PPI 5.5 year-over-year (consensus 4.5 last 3.3). December CPI 0.2 month-over-month (expected 0.3 last 0.1) 2.1 year-over-year (consensus 2.3 previous 2.3) Japans December Household Confidence 43.1 (expected 41.3 last 40.9) Australias November Retail Sales 0.2 month-over-month (expected 0.4 last 0.5) In news:In China, December PPI (5.5 year-over-year expected 4.5) climbed to a five-year high while inflation on the consumer level (2.1 year-over-year expected 2.3) was cooler than expected. The National Development and Reform Commission said that uncertainty will be on the rise in 2017, but the government will continue keeping tabs on economic performance. Major European indices trade with slim gains while SPAINS IBEX UNDERPERFORMS. UKS FTSE 0.4, GERMANYS DAX 0.2, FRANCES CAC 0.1, SPAINS IBEX -0.7.IN ECONOMIC DATA:FRANCES NOVEMBER INDUSTRIAL PRODUCTION 2.2 MONTH-OVER-MONTH (EXPECTED 0.6 LAST -0.1) SWISS DECEMBER UNEMPLOYMENT RATE HELD AT 3.3, AS EXPECTEDIN NEWS:IN GERMANY, JORG MEUTHEN, WHO IS THE ECONOMIST FOR THE RIGHT-WING AFD PARTY, SAID THE EUROZONE COULD BE SPLIT INTO TWO SEPARATE CURRENCY UNIONS-A STRONGER ONE CLUSTERED AROUND GERMANY WHILE A WEAKER ONE WOULD BE CLUSTERED AROUND FRANCE. RECALL THAT MARINE LE PEN, WHO IS EXPECTED TO BE IN A TIGHT THREE-WAY RACE FOR FRENCH PRESIDENCY IN APRIL, HAS VOICED SUPPORT FOR SIGNIFICANT CHANGES TO THE STRUCTURE OF THE EUROZONE. 8:08 AM GAIN CAPITAL REPORTS OPERATING METRICS FOR DECEMBER 2016 OTC ADV OF 8.6 BLN, -33.4 YY, ACTIVE OTC ACCOUNTS OF 129,036, -12.2 YY, FUTURES AVERAGE DAILY CONTRACTS OF 26,160, -21.2 YY ( GCAP ) : Institutional Segment Metrics ECN average daily volume of 9.2 billion, 36.0 YYECN volume of 202.1 billion, 36.0 YY Swap Dealer average daily volume of 3.2 billion, 20.3 YY Swap Dealer volume of 70.0 billion, 20.3YY 8:08 am GenMark Diagnostics sees Q4 rev in-line ( GNMK ). Sees Q4 revs 13 tO 14.9 MLN VS 14.80 MLN CAPITAL IQ CONSENSUS. THE COMPANY ALSO ANNOUNCED THAT IT FINISHED THE YEAR WITH MORE THAN 55 CUSTOMER AGREEMENTS IN PLACE TOTALING OVER 85 EPLEX INSTRUMENTS. quotFourth quarter revenue was in line with our expectations, despite a slow start to the flu season. Furthermore, we are very pleased with the increasing customer interest in our ePlex sample-to-answer system, particularly following our submissions to FDA last month. We finished the year with more than 55 agreements for over 85 ePlex instruments, many of which have already been installed in end-user sites. Customer feedback has been very positive, especially on ease of use and workflow. quotComplete 2016 fourth quarter and full year financial results will be announced during the Companys fourth quarter earnings call. At that time, the Company also anticipates providing 2017 financial guidance. 8:06 am Cognex announces they acquired Chiaro Technologies amp Webscan terms not disclosed ( CGNX ) : Co announces the recent acquisition of two technology companies in the fast-growing areas of 3D vision and industrial ID. On Nov 30, 2016, Cognex acquired Chiaro Technologies, maker of an innovative 3D machine vision sensor called Cloudburst. Chiaros Cloudburst sensor offers hiGH-SPEED, REAL-TIME 3D IMAGE STREAMING THAT IS USEFUL IN APPLICATIONS WHERE SPEED IS MORE IMPORTANT THAN CAPTURING A HIGH RESOLUTION IMAGE. ON DEC 9, 2016, COGNEX ALSO ACQUIRED WEBSCAN, A LEADER IN BARCODE VERIFICATION SOLUTIONS. WEBSCANS SOLUTION ENABLES MANUFACTURERS TO ENSURE THAT BARCODES MARKED ON PACKAGES, PARTS AND COMPONENTS ARE APPLIED ACCURATELY BEFORE ITEMS ARE SHIPPED, AND VERIFIES THAT CODES COMPLY WITH INDUSTRY STANDARDS. quotThe Cloudburst sensor enables Cognex to address a wider range of applications and price points in the fast-growing 3D vision market. And the combination of Webscans verification software with our rugged and flexible DataMan product line will enABLE COGNEX TO PROVIDE THE INDUSTRYS BROADEST RANGE OF HIGH-PERFORMANCE AND EASY-TO-USE VERIFICATION SOLUTIONS. quot 8:06 am Axcelis Tech announces shipments in 4Q16 of the Purion XE high energy implanter to multiple customers in the Asia Pacific Region guides Q4 revs on the high end of its guidance, and EPS above guidance ( ACLS ). quotWe expect fourth quarter revenue to be on the high end of our guidance, and EPS above guidance primarily driven by strong gross margin performance. We also continue to anticipate increased revenue in the first quarter of 2017.quotquotThese shipments represent the leading edge of expected strong capital investment in the memory sector in 2017. Memory growth will be driven by a strong Internet of Things market and the overall Connected World. quot 8:05 am Sangamo BioSci presents improvements to its technology platform for engineering highly specific zinc finger nucleases for therapeutic genome editing applications ( SGMO ). The data demonstrate genome editing of therapeutic gene targets in clinically relevant cell types, including high levels of targeted modification (80) of the BCL11A enhancer in hematopoietic stem and progenitor cells at clinical scale with no significant off-target activity. 8:05 am Alaska Air reports December operational results, traffic 5.6 ( ALK ). On a combined basis, Air Group reported a 5.6 percent increase in traffic on a 5.0 percent increase in capacity compared to December 2015. Load factor increased 0.5 points to 83.1 percent. These statistics include flighTS OPERATED BY ALASKA, VIRGIN AMERICA, HORIZON, AND THOSE UNDER THIRD-PARTY CAPACITY PURCHASE AGREEMENTS. 8:05 AM TORCHLIGHT ENERGY RESOURCES ANNOUNCES THAT DRILLING OF THE FLYING B RANCH 2 VERTICAL WELL WAS COMPLETED TO A TOTAL DEPTH OF 6,550 FEET PRELIM ANALYSIS RESULTED IN THE IDENTIFICATION OF 400 FEET OF CONTINUOUS PAY COMPRISED OF 80 FEET OF DEAN AND 320 FEET OF WOLFCAMP AampB FORMATIONS ( TRCH ). Torchlight has planned a completion procedure to commence on January 18th with a scheduled fracing of the well which will target the 400 of pay identified in the Wolfcamp and Dean formations. The Company plans to perform a significantly larger multiple-stage frac than previously employed where they will utilize 600,000 lbs. of sand pumped at a fluid rate of 75-100 barrels per minute. Torchlight expects the well to be a vertical producer providing further confirmation for economic horizontal development potential. 8:04 am Hill-Rom to acquire Mortara Instrument for 330 mln in cash ( HRC ) : Mortara Instrument is a privately held company in diagnostic cardiology and patient monitoring solutions, technologies, and devices. Hill-Rom anticipates the structure of the acquisition will allow the company tO QUALIFY FOR A SIGNIFICANT TAX BENEFIT, WHICH AT A NET PRESENT VALUE OF APPROXIMATELY 40 MILLION REDUCES THE EFFECTIVE PURCHASE PRICE TO APPROXIMATELY 290 MILLION. HILL-ROMS ACQUISITION OF MORTARA IS EXPECTED TO ACCELERATE HILL-ROMS REVENUE GROWTH AND BE ACCRETIVE TO BOTH GROSS AND OPERATING MARGINS. EXCLUDING SPECIAL ITEMS, THE TRANSACTION IS EXPECTED TO BE MODESTLY ACCRETIVE TO HILL-ROMS FISCAL 2017 ADJUSTED EARNINGS PER SHARE. THE COMPANY PLANS TO REALIZE ANNUAL OPERATIONAL SYNERGIES OF AT LEAST 10 MILLION, AND EXPECTS THE TRANSACTION TO SUPPORT ITS MARGIN EXPANSION OBJECTIVES AND DRIVE GREATER ACCRETION TO ADJUSTED EARNINGS PER DILUTED SHARE BEYOND 2017. THE COMPANY WILL UPDATE ITS FISCAL 2017 FINANCIAL GUIDANCE AFTER THE TRANSACTION CLOSES. HILL-ROM INTENDS TO FINANCE THE TRANSACTION THROUGH A COMBINATION OF CASH ON HAND AND BORROWINGS UNDER EXISTING CREDIT FACILITIES. THE TRANSACTION IS EXPECTED TO CLOSE IN HILL-ROMS FISCAL SECOND QUARTER OF 2017. 8:04 AM PIONEER POWER SOLUTIONS SEES FY17 EPS ABOVE SINGLE EST REVS IN LINE WITH SINGLE EST ( PPSI ). Co issues guidance for FY17 (Dec), sees EPS of 0.83-0.91 vs. 0.52 single analyst estimate sees FY17 (Dec) revs of 120-127 mln vs. 124.80 MLN SINGLE ANALYST ESTIMATE. quotThis outlook represents continued margin expansion and further improvement in profitability, as we continue to benefit from the operational improvements we have made and continue to make. We remain focused on higher margin opportunities, resulting in targeted growth. We see continued strong demand for our solutions, as evidenced by our solid backlog of 39.6 million as of December 31, 2016, up from 28.7 million in backlog at December 31, 2015. In particular, we are expanding our presence in the areas of microgrids, distributed generation, on-site generation service and data center solutions. The continued bottom-line improvements are due to our ability to extract operational LEVERAGE FROM OUR BUSINESS, AND WE ARE CONFIDENT WE CAN FURTHER EXPAND PROFITABILITY AND CASH GENERATION AS WE SCALE THE BUSINESS. quot 8:03 am ZIOPHARM amp Intrexon ( XON ) announce cooperative research and development agreement with the National Cancer Institute utilizing sleeping beauty system to generate T cells targeting neoantigens ( ZIOP ) : quotTreating liquid tumors with chimeric antigen receptors has yielded extraordinary results with genetically engineered T cells and the next stage in the evolution of this immunotherapy is the expression of T-cell receptors to target solid tumors, quot said Laurence Cooper, MD, PhD, Chief Executive Officer of ZIOPHARM. quotThrough use of the scalable non-viral Sleeping Beauty platform to express an array of TCRs that recognize neoantigens within each patients tumor, we can customize T-cell therapies and enhance their function through cytokines and switches. quot 8:03 am Immunomedics stockholder venBio responds to recent Board nominees by the co and touts its 4 candidates to the Board ( IMMU ) : venBio Select Advisor, which owns a 9 stake in IMMU and is its largest stockholder, responds to the announcement by Immunomedics of new nominees for the Board of Directors as well as leadership adjustments. quotWe strongly believe that this announcement from Immunomedics is too little, too late, and indicates that they do not understand the severity OF OUR CONCERNS, WHICH WE BELIEVE ARE SHARED BY MANY STOCKHOLDERS. DESPITE THE COMPANYS RECENT ACTIONS, IT HAS NOT ASSEMBLED THE EXPERTISE NEEDED TO OVERSEE ITS MAIN ASSET, IMMU-132, AND THE CRITICAL PERIOD AHEAD FOR IT -- NAMELY THE LICENSING AND PARTNERING PERIOD. WE ARE ALSO STILL CONCERNED ABOUT THE LONG-TERM FUTURE OF THE COMPANY. quotFirm says quotImmunomedics has been mismanaged for years. and the Companys announced plan today is simply an example of more of the same mismanagement. While we welcome the long-overdue announcement that the Company will begin a search for a new CEO, we believe it is imperative that this search and succession be led by a well-qualified independent Board. The nominees put forth today by Immunomedics fall short of our slate. quotquotWe believe that investors should exercise their opportunity to voice their frustration at the strategic missteps of the Companys leadership by voting on thE GOLD PROXY CARD WHEN THEY RECEIVE IT. quot 8:03 am Hill-Rom expects Q4 EPS to be at the lower end of previous guidance range of 0.75-0.77, Capital IQ consensus 0.76 Sees revenue of approx 637 mln, Capital IQ consensus 656 mln ( HRC ). Hill-Rom expects adjusted earnings to be at the lower end of its previously-issued guidance of 0.75 to 0.77 per diluted share. Hill-Rom is also reaffirming its 2017 full-year adjusted earnings guidance of 3.74 to 3.82 per diluted share, as provided in its fourth quarter 2016 earnings announcement. For the fiscal first quarter, worldwide revenue of 637 million (Capital IQ consensus 656 mln) declined 4 percent versus the first quarter last year. In addition TO A DIFFICULT COMPARISON TO THE PRIOR-YEAR PERIOD, FIRST QUARTER REVENUE GROWTH WAS IMPACTED BY THE TIMING OF CERTAIN INTERNATIONAL AND U. S. DISTRIBUTOR ORDERS, AND LOWER REVENUE FROM BUSINESSES THE COMPANY DIVESTED DURING THE MOST RECENT QUARTER OR PLANS TO DIVEST IN 2017. 8:02 AM QUICKLOGIC SEES Q4 REVS AT MID-POINT OF GUIDANCE ( QUIK ). Co sees Q4 revs 2.9 mln (midpoint of guidance range) vs 2.90 mln two analyst estimate. This revenue comprised approximately 1.6 million of new product revenue and 1.3 million of mature product revenue. The Company ended the fourth quarter with a higher than anticipated cash balance of approximately 14.9 million. quotIm very pleased with the strategic progress we maDE DURING THE FOURTH QUARTER AND THE ACCELERATED MOMENTUM WE GATHERED DURING THE 2017 CONSUMER ELECTRONICS SHOW IN LAS VEGAS THIS PAST WEEK. GIVEN THIS PROGRESS AND THE MOMENTUM, I BELIEVE WE ARE ON TRACK TO REALIZE THE STRATEGIC OBJECTIVES WEVE PREVIOUSLY OUTLINED FOR 2017.quot 8:01 am Orthofix sees Q4 rev above consensus FY17 rev below consensus, EBITDA margin consistent with FY16 ( OFIX ). Sees Q4 revs 109 mln vs 104.73 mln Capital IQ Consensus these preliminary results represent reported sales growth of 3.7 and constant currency sales growth of 4.2 over the fourth quarter 2015. Sees FY17 rev 407-411 mln vs. 418 mln consensus when normalizing for the negative impact of foreign currency of 4.8 million and a loss of revenue of 5.3 million in 2017 due to planned distribution restructuring in Brazil and Puerto Rico and the wind down of a non-core business, the growth rate is expected to be 1.5 to 2.5. Additionally, the Company expects full year 2017 adjusted EBITDA margins to be generally consistent with 2016 8:00 am Arcadia Biosciences obtains U. S. FDA GRAS status for SONOVA GLA safflower oil ( RKDA ). Co announces that the FDA has accepted its conclusion that its SONOVA GLA safflower oil is quotgenerally recognized as safequot for use in nutritional beverages and medical foods. Arcadia produces GLA safflower nutritional oils with high concentrations of gamma-linolenic acid (:GLA). These oils are marketed by Arcadia under the SONOVA brand and are currently used in nutritional supplement products. 7:59 am On The Wires (:WIRES). CGI (GIB) announced it has won a new three year, 5 million, contract with Englands Environment Agency to design, deliver and run Englands new Future Flood Forecasting System. Flood Forecasting System will make use of the latest scalable cloud computing, enabling the Environment Agency to produce and share flood forecasts and products with greater efficiency and effectiveness. Agrium Inc. (AGU) anNOUNCED THAT IT SUCCESSFULLY COMPLETED CONSTRUCTION OF THE UREA PLANT AT ITS NITROGEN FACILITY IN BORGER, TEXAS, WITHIN THE PREVIOUSLY DISCLOSED REVISED TIME LINE AND COST PARAMETERS. COMMISSIONING OF THE NEW 610,000 TONNE UREA FACILITY, OF WHICH 100,000 TONNES OF UREA TONNE EQUIVALENT WILL BE DIESEL EXHAUST FLUID, IS UNDERWAY AND PRODUCTION IS EXPECTED TO COMMENCE IN THE FIRST QUARTER OF 2017.SERA PROGNOSTICS ENTERED INTO A STRATEGIC COLLABORATION WITH LABORATORY CORPORATION OF AMERICA (LH) TO BE THE EXCLUSIVE U. S. DISTRIBUTOR OF SERAS PRETRM TEST. IN ADDITION, LABCORP WILL LEAD SERAS 40 MLN SERIES C FINANCING. PROCEEDS FROM THE SERIES C FINANCING, WHICH INCLUDES EXISTING INVESTORS, ENABLE SERA TO CONTINUE BUILDING CLINICAL EVIDENCE TO SUPPORT REIMBURSEMENT AND INSURANCE COVERAGE DECISIONS, AS WELL AS EXPAND COMMERCIALIZATION NATIONWIDE FOR THE PRETRM TEST. WINGSTOP (WING) BECAME THE FIRST RESTAURANT BRAND TO OFFER VOICE-ACTIVATED ORDERING WITH MENU ITEM CUSTOMIZATION THROUGH AMAZON (AMZN) ALEXA. 7:58 AM CHIPOTLE MEXICAN GRILL FOLLOW UP: SEES Q4 EPS WELL BELOW CONSENSUS WITH IMPROVEMENT IN DECEMBER SALES AS COMPS EASED ADDS 100 MLN TO BUYBACK ( CMG ) : Sees Q4 EPS 0.50-0.58 vs 0.98 Capital IQ Consensus revs 1.035 bln vs 1.05 bln Capital IQ Consensus comps -4.8 vs. ests near -3.5. Comparable restaurant sales for the quarTER DECREASED 4.8, WHICH INCLUDES THE BENEFIT OF 0.5 RELATED TO PREVIOUSLY DEFERRED REVENUE THAT WAS RECOGNIZED IN THE FOURTH QUARTER. COMPARABLE RESTAURANT SALES DECREASED 20.2 IN OCTOBER 2016, DECREASED 1.4 IN NOVEMBER 2016, AND INCREASED 14.7 IN DECEMBER 2016. SALES COMPARISONS ARE LAPPING AN EASIER COMPARE DUE TO LOWER SALES LEVELS IN NOVEMBER AND DECEMBER 2015. OPERATING MARGIN 13-14. quotDuring the quarter we incurred higher expenses compared to our originally-forecaSTED AMOUNTS IN OTHER OPERATING COSTS, DRIVEN BY INCREASED PROMOTIONAL SPEND AND COSTS RELATED TO TESTING TELEVISION ADVERTISING. OUR MARKETING AND PROMOTIONAL EXPENSES DURING THE QUARTER TOTALED 4.7 OF SALES. WE ALSO INCURRED HIGHER FOOD COSTS COMPARED TO OUR ORIGINALLY-FORECASTED AMOUNTS AS A RESULT OF INCREASED MARKET COSTS FOR AVOCADOS. quot This report is also filed to announce that Chipotles Board of Directors has authorized repurchases of Chipotle common stock with a total aggregate purchase price of 100 million, exclusive of commissions. This repurchase is in addition to previously announced repurchase authorizations totaling 2.1 billion. 7:52 am Chipotle Mexican Grill moving lower by 3 on downside guidance Q4 comps -4.8 ( CMG ). Sees Q4 EPS of 0.50-0.58 vs 0.98 Capital IQ Consensus Estimate revs 1.035 bln vs 1.05 bln Capital IQ Consensus Estimate comps -4.8. 7:48 am Healthways changes name to Tivity Health will begin trading under its new ticker TVTY on January 11 ( HWAY ). 7:32 am Zimmer Biomet sees Q4 sales of approx 2.013 bln, Capital IQ consensus 1.971 bln sees FY16 EPS at upper end of prior guidance ( ZBH ). Expects fourth quarter net sales to be approximately 2.013 billion (Capital IQ consensus 1.971 bln), an increase of 4.1 over the prioR YEAR PERIOD. ON AN ADJUSTED, CONSTANT CURRENCY BASIS, REVENUE INCREASED BY 4.4 OVER THE PRIOR YEAR PERIOD, WITH THE RECENTLY ACQUIRED LDR HOLDING CORPORATION CONTRIBUTING APPROXIMATELY 230 BASIS POINTS. PREVIOUSLY, THE COMPANY HAD ESTIMATED FOURTH QUARTER REVENUE GROWTH TO BE IN A RANGE OF 1.0 TO 2.0 ON A SIMILAR BASIS. PRELIMINARY FULL YEAR NET SALES ARE PROJECTED TO BE 7.684 BILLION, AN INCREASE OF 28.1 OVER THE PRIOR YEAR. FY16 REVENUES INCREASED BY 2.3 ON A CONSTANT CURRENCY, ADJUSTED PRO FORMA BASIS, EXCLUDING THE CONTRIBUTION FROM THE LDR TRANSACTION. PREVIOUSLY, THE COMPANY HAD ESTIMATED FULL YEAR REVENUE GROWTH TO BE IN A RANGE OF 1.65 TO 1.90 ON A SIMILAR BASIS. THE COMPANY IS UNABLE TO PROVIDE UPDATED GAAP (REPORTED) GUIDANCE FOR FULL-YEAR 2016 DILUTED EARNINGS PER SHARE, WITHOUT UNREASONABLE EFFORTS, AS THE COMPANY IS FINALIZING THE ACCOUNTING FOR CERTAIN INTEGRATION-RELATED ITEMS THAT ARE EXCLUDED FROM THE COMPUTATION OF ADJUSTED DILUTED EARNINGS PER SHARE. THE COMPANY NOW EXPECTS FULL YEAR 2016 ADJUSTED DILUTED EARNINGS PER SHARE TO BE TOWARDS THE UPPER END OF THE PREVIOUSLY ESTIMATED RANGE OF 7.90 TO 7.95. 7:31 AM FIRSTSERVICE ACQUIRES PAUL DAVIS NATIONAL TERMS NOT DISCLOSED ( FSV ) : Paul Davis National is a specialized commercial and large loss operation within Paul Davis Restoration. The terms of the transaction were not disclosed. 7:31 am WNS to acquire Denali Sourcing Services for 40 mln in cash expects to be accretive to fiscal 2017 earnings ( WNS ) : Denali Sourcing Services is a provider of strategic procurement BPM solutions. The acquisition of Denali Sourcing Services expected to close in Jan 2017. Cash consideration for the transaction is 40.0 mln plus adjustments for cash and working capital. WNS intends to fund the consideration primarily with long-term debt. The acquisition is expected to contribute 3 mln in rev for WNS in the fiscal year ending Mar 31, 2017, and to be accretive to fiscal 2017 earnings. 7:30 am Coupa Software acquires Spend360 International terms not disclosed ( COUP ). Based outside London, Spend360 is an analytics solution that uses deep machine learning and artificial intelligence to structure and cleanse data in a format that finance and procurement can actually use. Coupa expects the capabilities from Spend360 to be made available to select Coupa customers later this year. The acquisition is not expected to have a material impact on Coupas results of operations or financial condition for its fourth quarter or fiscal year ending January 31, 2017. 7:30 am Ascena Retail Group (halted) reports holiday comps down 3.1 lowers Q2, FY17 EPS guidance below consensus ( ASNA ). Reports holiday comps down 3.1 (guided quarter down 4-5)Ann Taylor -8.2, Loft -1.8, Maurices -7.1, Dressbarn -4.6, Lane Bryant -5.1, catherines 1.6Lowers Q2 EPS to (0.11-0.08) from (0.05)-0.00 vs (0.03) Capital IQ Consensus. LOWERS FY17 EPS TO 0.37-0.42 FROM 0.60-0.65 VS. 0.58 CONSENSUS. 7:30 AM ON THE WIRES (:WIRES). ENERGY FUELS INC. (UUUU) ANNOUNCED THAT THE U. S. BUREAU OF LAND MANAGEMENT HAS ISSUED A FINAL ENVIRONMENTAL IMPACT STATEMENT AND RECORD OF DECISION (THE quotRODquot) for the Companys 100-owned Sheep Mountain Project located in the Crooks Gap Mining District of central Wyoming. The Sheep Mountain Project is a large-scale, formerly-producing, conventional uranium mine with the potential to become a long-term uranium production center in a higher price environment. The issuance of the EIS, the ROD and the Mine Permit are the last major government approvals required to commence mining at this project, as the Company continues to evaluate options for processing the resources that may be mined at the project, including toll processing at other facilities in the region and the licensing and construction of its own onsite facility. Brown Gibbons Lang amp Company announced the sale of Groot Industries to Waste Connections (WCN). BGLs Environmental amp Industrial Services team served as the financial advisor to Groot in the transaction. The specific terms of the transaction were not disclosed. 7:27 am Visteon in slide presentation sees FY16 amp FY17 guidance in line with estimates ( VC ). Co issues in-line guidance for FY16 (Dec), sees FY16 (Dec) revs of 3.1 bln vs. 3.11 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 340-345 mlnCo issues in-line guidance for FY17 (Dec), sees FY17 (Dec) revs of 3.1-3.2 bln vs. 3.18 bln Capital IQ Consensus Estimate sees adjusted EBITDA of 355-370 mln 7:21 am European Markets Update: FTSE 0.4, DAX 0.2, CAC UNCH (:SUMRX) : Major European indices trade with slim gains while Spains IBEX (-0.7) underperforms. In Germany, Jorg Meuthen, who is the economist for the right-wing AFD party, said the Eurozone could be split into two separate currency unions-a stronger one clustered around Germany while a weaker one would be clustered around France. Recall that Marine Le Pen, who is expected to be in a tight three-way race for French presidency in April, has voiced support for significant changes to the structure of the eurozone. Economic data was limited: Frances November Industrial Production 2.2 month-over-month (expected 0.6 last -0.1) Swiss December Unemployment Rate held at 3.3, as expected ---Equity Markets--- UKs FTSE is higher by 0.4 with miners showing relative strength. Anglo American, Rio Tinto, BHP BillitON, ANTOFAGASTA, AND FRESNILLO POSTED GAINS BETWEEN 2.3 AND 6.4. CONSUMER NAMES HAVE ALSO CONTRIBUTED TO THE ADVANCE WITH TESCO, MORRISON SUPERMARKETS, INTERCONTINENTAL HOTELS, MERLIN ENTERTAINMENTS, NEXT, AND SAINSBURY ADDING BETWEEN 1.8 AND 4.7. HOMEBUILDERS TAYLOR WIMPEY, PERSIMMON, AND BARRATT DEVELOPMENTS ARE UP BETWEEN 1.3 AND 1.8. GERMANYS DAX HAS ADDED 0.2. SIEMENS HAS JUMPED 1.7 IN REACTION TO AN UPGRADE. WHILE EXPORTERS CONTINENTAL AND VOLKSWAGEN HOLD RESPECTIVE GAINS OF 1.8 AND 1.3. FINANCIALS HAVE BEEN WEAK WITH COMMERZBANK AND DEUTSCHE BANK DOWN 2.2 AND 2.7, RESPECTIVELY. FRANCES CAC SITS JUST ABOVE ITS FLAT LINE, LOOKING TO AVOID ITS SECOND CONSECUTIVE DECLINE. RECENT STRENGTH IN COMMODITY PRICES HAS SENT ARCELORMITTAL TO THE TOP OF THE DAYS LEADERBOARD WITH A GAIN OF 2.5. AUTOMAKERS RENAULT AND PEUGEOT ARE UP 2.3 AND 0.6, RESPECTIVELY, WHILE FINANCIALS ARE MIXED. SOCIETE GENERALE HAS ADDED 0.7 WHILE CREDIT AGRICOLE AND BNP PARIBAS ARE BOTH DOWN NEAR 0.2. COUNTERCYCLICAL NAMES LIKE ORANGE AND VEOLIA ENVIRONNEMENT LAG, DOWN 1.4 AND 2.4, RESPECTIVELY. SPAINS IBEX TRADES LOWER BY 0.7 AMID WEAKNESS IN FINANCIALS. BANCO POPULAR, BBVA, BANKIA, BANCO SABADELL, AND CAIXABANK ARE DOWN BETWEEN 0.6 AND 2.8. 7:21 AM DEUTSCHE LUFTHANSA AG REPORTS DECEMBER TRAFFIC DATA ( DLAKY ). Co reported total December passengers of 7.79 mln, up 5.9 YoY. Available seat kilometers 20.931 mln, up 5.4 YoY. Cargo Load Factor of 70.3 vs 66.6 last year. 7:18 am Nabors Industries prices 500 mln private offering of its 0.75 exchangeable senior unsecured notes due 2024 ( NBR ). The net proceeds from the offering will be used to prepay the remaining balance of NIIs unsecured term loan, which matures in 2020, as well as to pay the cost of the capped call transaction entered into with respect to Nabors common shares. Any remaining net proceeds from the offering will be used for general corporate purposes, including TO REPURCHASE OR REPAY OTHER INDEBTEDNESS. THE NOTES WILL BEAR INTEREST AT A RATE OF 0.75YEAR UNTIL MATURITY, PAYABLE SEMI-ANNUALLY IN ARREARS ON JAN 15 AND JULY 15 OF EACH YEAR, BEGINNING ON JULY 15, 2017. THE NOTES WILL BE EXCHANGEABLE, UNDER CERTAIN CONDITIONS, AT AN INITIAL EXCHANGE RATE OF 39.7488 COMMON SHARES OF NABORS PER 1,000 PRINCIPAL AMOUNT OF NOTES, SUBJECT TO ADJUSTMENT, WHICH REPRESENTS AN 40.0 EXCHANGE PREMIUM OVER THE LAST REPORTED SALE PRICE OF 17.97 PER COMMON SHARE OF NABORS ON THE NYSE ON JAN 9, 2017. NABORS AND NII ENTERED INTO PRIVATELY NEGOTIATED CAPPED CALL TRANSACTIONS WITH ONE OR MORE OF THE INITIAL PURCHASERS ANDOR THEIR AFFILIATES. THE CAPPED CALL TRANSACTIONS COVER THE NUMBER OF NABORS COMMON SHARES THAT WILL INITIALLY UNDERLIE THE NOTES. THE CAPPED CALL TRANSACTIONS ARE EXPECTED TO REDUCE POTENTIAL DILUTION TO NABORS COMMON SHARES ANDOR OFFSET POTENTIAL CASH PAYMENTS NABORS IS REQUIRED TO MAKE IN EXCESS OF THE PRINCIPAL AMOUNT UPON ANY EXCHANGE OF NOTES. SUCH REDUCTION ANDOR OFFSET IS SUBJECT TO A CAP REPRESENTING A PRICE PER SHARE OF 31.4475, AN 75.0 PREMIUM OVER THE LAST REPORTED SALE PRICE OF 17.97COMMON SHARE OF NABORS ON THE NYSE ON JAN 9, 2017. 7:09 AM NEXSTAR EXTENDS THE EMPLOYMENT AGREEMENT OF CFO THOMAS E. CARTER THROUGH DECEMBER 31, 2021 EXTENSION SUPERSEDES CARTERS PRIOR EMPLOYMENT AGREEMENT WHICH WAS TO CONCLUDE IN AUGUST 2018 ( NXST ). 7:02 am Pluristem Therapeutics announced that its Phase III study of its PLX-PAD cells in the treatment of critical limb ischemia was cleared by the FDA expects to begin enrolling patients in its Phase III study in both the U. S. and Europe during 1H17 ( PSTI ). 7:02 am Evolving Systems (thinly-traded) announces that one of the market-leading wireless carriers in Southeast Asia has selected its Acquisition and Activation Managed Service to support its base of 60 mln subscribers ( EVOL ). 7:02 am Electro ScienTIFIC REPORTS PRELIMINARY Q3 ORDERS ARE EXPECTED TO BE 42-44 MLN ( ESIO ) : In conjunction with todays presentation at the Needham Growth Conference. the company is announcing that preliminary orders for its 3Q17 are expected to be 42-44 mln. Cash and investments at the end of the quarter are expected to be 54-55 million. The company also announced that on January 9, 2017, it closed a 14 million ten-year term loan with First Technology Federal CREDIT UNION IN BEAVERTON, OREGON. 7:02 AM PIXELWORKS SEES Q4 REVS AT HIGH END OF GUIDANCE, EXPECTS TO REPORT GAAP PROFITABILITY ( PXLW ). Co sees Q4 revs of approximately 16 mln (Guidance was for 15-16 mln) vs 15.49 mln Capital IQ Consensus Estimate. The Company also expects to report a profit for the fourth quarter on a fully diluted GAAP basis, compared to previous guidance of a loss of 0.06 per share to breakeven. Additionally, the Company generated cash from operations in the fourth quaRTER AND ANTICIPATES A QUARTER-END CASH BALANCE OF APPROXIMATELY 19.6 MILLION, NET OF ANY BORROWING, WHICH IS APPROXIMATELY 3 MILLION GREATER THAN AT THE END OF THE THIRD QUARTER. 7:02 AM GILDAN ACTIVEWEAR HAS EMERGED AS THE WINNER IN THE COURT SUPERVISED AUCTION TO ACQUIRE THE AMERICAN APPAREL BRAND AND CERTAIN ASSETS FROM AMERICAN APPAREL, LLC (:APPCQ) FOR 88 MLN IN CASH ( GIL ). The transaction is subject to Bankruptcy Court approval on January 12, 2017 and Gildan anticipates completing the acquisition by early February. The Company will provide details on the projected financial contribution of the acquisition on the Companys earnings in February, when it reports its full year 2016 earnings results and initiates guidance for 2017. 7:01 am xG Technology regains full compliance with all listing requirements of the Nasdaq ( XGTI ). 7:01 am NeuroMetrix reports Q4 demand for its Quell Technology, invoiced value of shipments totaled approximately 3.5 mln (19 QQ) ( NURO ). The Quell invoiced value in Q4 2016 reflects shipments of approximately 14,300 devices and 20,000 reorder electrodes, a growth rate of 18 in devices and 39 in electrodes from Q3 2016. To date, the Company has shipped nearly 60,000 devices. 7:01 am Abbott Labs announces CE mark for its Alinity S blood and plasma screening system ( ABT ) : The Alinity s System will help transform the blood and plasma screening process in terms of speed, capacity and quotwalk-awayquot time (i. e. when lab professionals are free to manage other responsibilities while the instrument processes samples without direct interaction) as a result of a number of new features: Expands capacity to run up to 600 tests per hour, at least twice as much as competitive standalone instruments. Improves centers ability to track all activities and actions associated with the testing and processing of each donation in accordance with relevant legislation and requirements. Increases walk-away time to a minimum of three hours. Gives laboratory professionals the ability to continuously load and unload samples and supplies without pausing or stopping the system. Features an intuitive software interface, menu design and sample loading layout, shared with other Alinity instruments, making it easy for lab technicians to learn and use. 7:01 am NovoCure reports prelim Q4 results 1,091 active patients at Dec. 31, 2016, an increase of 80 YY ( NVCR ). There were 1,091 active patients on Optune therapy on Dec. 31, 2016, an increase of 80 percent VERSUS DEC. 31, 2015. OF THE ACTIVE PATIENTS, 835 WERE IN THE U. S. AND 256 WERE IN NOVOCURES EMEA MARKETS. 706 PRESCRIPTIONS WERE RECEIVED IN THE FOURTH QUARTER OF 2016, AN INCREASE OF 27 PERCENT VERSUS THE FOURTH QUARTER OF 2015. 544 OF THE PRESCRIPTIONS WERE RECEIVED IN THE U. S. AND 162 WERE RECEIVED OUTSIDE OF THE U. S. PRIMARILY IN EUROPE. quotThe fourth quarter of 2016 was the eighth consecutive quarter of active patient growth for Novocure since the presentation of our successful EF-14 phase 3 pivotal trial data in newly diagnosed glioblastoma (:GBM),quot said Asaf Danziger, Novocures Chief Executive Officer. quotAs of Dec. 31, 2016, we had nearly 1,100 active patients on treatment, including 256 patients in EMEA, reflecting the increasing importance of our non-U. S. markets. quot quotThe fourth quarter of 2016 was also marked by significant clinical milestones. A long-term analysis of the EF-14 data, presented at the 21st Annual Scientific Meeting of the Society for Neuro-Oncology in November, demonstrated a 70 percent improvement in survival rate at four years for patients treated with Optune together with temozolomide compared to patients treated with temozolomide alone. During our RampD day, we also shared topline results from phase 2 pilot studies in advanced pancreatic cancer, recurrent ovarian cancer and mesothelioma, suggesting that Tumor Treating Fields, when added to standard of care treatments, may improve patient outcomes. quot 7:00 am Investment Tech reports December 2016 trading volume was 3.1 bln shares, -6 YY, AND ADV WAS 150 MLN SHARES, -6 YY ( ITG ) : There were 21 trading days in both December 2016 and November 2016 and 22 trading days in December 2015. 6:59 am On The Wires (:WIRES). BioLife Solutions (BLFS) announced that it has reached an agreement to extend the maturity date and repayment schedule of its outstanding 4 million credit facility. Denison Mines Corp. (DNN) announced that it has executed an agreement with the partners of the Wheeler River Joint Venture that will result in an increase in Denisons ownership of the Wheeler River project to up to approximately 66 (currently 60) by the end of 2018. The Wheeler River property is a joint venture between Denison (60 ownership and operator), Cameco Corp. (30 ownership), and JCU Canada Exploration (10 ownership). Under the terms of the Agreement, the JV Parties have agreed to allow for a one-time election by Cameco to fund 50 of its ordinary share of joint venture expenses in 2017 and 2018. Transenterix (TRXC) says it is on track to file the 510(k) for the Senhance System in early 2017 and expects to receive clearance in late 2017.Richmont Mines (RIC) announced that it will transfer the listing of its common shares from NYSE MKT to the New York Stock Exchange (:NYSE). 6:56 am Endeavour Silver reports 2016 production of 5.4 mln oz silver and 57,375 oz gold, slightly above guidance on gold and slightly below guidance on silver ( EXK ). Silver equivalent production totalled 9.7 million oz at a 75:1 silver: gold ratio, in line with guidance. Silver production in 4Q16 was 1,088,845 oz and gold production was 44,402 oz, for silver equivalent production of 1.9 million oz. Co expects to release updated reserve and resource estimates and 2017 production and cost guidance within the next two weeks. 6:55 am Asian Markets Close: Nikkei -0.8, Hang Seng 0.8, Shanghai -0.3 (:SUMRX) : Equity indices in the Asia-Pacific region ended Tuesday on a mostly lower note. The yen advanced against the dollar in overnight action, but that move has been retraced entirely. In China, December PPI (5.5 year-over-year expected 4.5) climbed to a five-year high while inflation on the consumer level (2.1 year-over-year expected 2.3) was cooler than expected. The National Development and Reform Commission said that uncertainty will be on the rise in 2017, but the government will continue keeping tabs on economic performance. In economic data: Chinas December PPI 5.5 year-over-year (consensus 4.5 last 3.3). December CPI 0.2 month-over-month (expected 0.3 last 0.1) 2.1 year-over-yeAR (CONSENSUS 2.3 PREVIOUS 2.3) JAPANS DECEMBER HOUSEHOLD CONFIDENCE 43.1 (EXPECTED 41.3 LAST 40.9) AUSTRALIAS NOVEMBER RETAIL SALES 0.2 MONTH-OVER-MONTH (EXPECTED 0.4 LAST 0.5) ---EQUITY MARKETS--- JAPANS NIKKEI LOST 0.8 AFTER BEING CLOSED ON MONDAY. FAST RETAILING, OKI ELECTRIC, DAI-ICHI LIFE INSURANCE, KONAMI, ISUZU MOTORS, HINO MOTORS, CREDIT SAISON, AND NGK INSULATORS LOST BETWEEN 1.8 AND 2.6. ON THE UPSIDE, SONY, TOKYO ELECTRON, AND DENTSU POSTED GAINS BETWEEN 1.2 AND 2.4. HONG KONGS HANG SENG CLIMBED 0.8 WITH SUPPORT FROM MOST COMPONENTS. PROPERTY NAMES LIKE SINO LAND, NEW WORLD DEVELOPMENT, HENDERSON LAND, CHEUNG KONG PROPERTY HOLDINGS, AND CHINA RESOURCES LAND ADVANCED BETWEEN 1.0 AND 1.9. TELECOM NAMES LAGGED WITH CHINA UNICOM HONG KONG FALLING 2.3 AND CHINA MOBILE SHEDDING 0.3. CHINAS SHANGHAI COMPOSITE SLIPPED 0.3. GITI TIRE, SHANGHAI MATERIAL TRADING, GREATTOWN HOLDINGS, AND SHANGHAI DIESEL ENGINE FELL BETWEEN 4.4 AND 5.8. INDIAS SENSEX ADVANCED 0.7 WITH GROWTH-SENSITIVE NAMES LEADING THE RALLY. ADANI PORTS, TATA MOTORS, TATA STEEL, AND ASIAN PAINTS ADDED BETWEEN 1.5 AND 3.3. FINANCIALS WERE MOSTLY HIGHER WITH HDFC BANK, ICIC BANK, AND SBI RISING BETWEEN 0.3 AND 1.5 WHILE AXIS BANK LOST 1.2. ---FX--- USDJPY UNCH AT 115.95 USDCNY -0.2 TO 6.9226USDINR UNCH AT 68.173 6:50 AM VISTEON ANNOUNCES A NEW 400 MLN SHARE REPURCHASE AUTHORIZATION ( VC ). 6:45 am Express SEES Q4 COMPS BELOW GUIDANCE REAFFIRMS EPS ( EXPR ). Co sees Q4 comps down 13 vs. negative low double digit guidance reaffirms Q4 EPS 0.26-0.30 vs 0.29 Capital IQ Consensus. quotBased on our holiday results, we are reaffirming our fourth quarter and full year EPS guidance. Our store performance continues to be impacted by challenging mall traffic trends and a more promotional retail environment. However, we remain pleased with our e-commerce sales performance, which continues to trend positively year-over-year. quot 6:45 am Teleflex annouNCES ITS ARROW VPS RHYTHM DEVICE WITH OPTIONAL TIPTRACKER TECHNOLOGY HAS BEEN ISSUED 510(K) CLEARANCE TO COMMERCIALIZE THE DEVICE IN THE US ( TFX ). 6:41 am West Marine in slide presentation sees FY16 revs in line with consensus ( WMAR ). Co issues in-line guidance for FY16 (Dec), sees FY16 (Dec) revs of down 1 to flat to 697-710 mln vs. 703.45 mln Capital IQ Consensus Estimate sees comps flat to 1 6:36 am Prestige Brands repeats FY17 EPS and revenue guidance in slide presentation ( PBH ). Co repeats guidance for FY17 (MAR), SEES EPS OF 2.30-2.36 VS. 2.34 CAPITAL IQ CONSENSUS ESTIMATE SEES FY17 (MAR) REVS OF 4.5-6.0 TO 842.5-854.4 MLN VS. 844.06 MLN CAPITAL IQ CONSENSUS ESTIMATE CO SEES ADJUSTED CASH FLOW GUIDANCE OF 190 MLN OR MORE. 6:31 AM SOUTHWEST AIR REPORTS DEC TRAFFIC RAISES Q4 UNIT REV GUIDANCE ( LUV ). ASMs increased 4.8 to 12.6 bln in DEC 2016, COMPARED WITH DEC 2015 ASMS OF 12.1 BLN. THE DEC 2016 LOAD FACTOR WAS 82.6, COMPARED WITH 83.0 PERCENT IN DEC 2015. BASED ON THESE RESULTS AND AN IMPROVEMENT IN CLOSE-IN YIELDS, THE CO NOW ESTIMATES ITS FOURTH QUARTER 2016 OPERATING REV PER ASM WILL DECLINE IN THE 3.0 TO 4.0 RANGE (PRIOR 4-5), AS COMPARED WITH FOURTH QUARTER 2015. THE COMPANY FLEW 10.4 BILLION REVENUE PASSENGER MILES IN DEC 2016, AN INCREASE OF 4.2 PERCENT FROM THE 10.0 BILLION RPMS FLOWN IN DEC 2015. 6:22 AM STRONGBRIDGE BIOPHARMA JANUARY PRESENTATION SLIDES ( SBBP ). Launch of Keveyis expected in April 2017. Keveyisis the first and only FDA-approved therapy indicated for the treatment of:Primary hyperkalemic periodic paralysisPrimary hypokalemic periodic paralysisRelated variantsCOR-003 SONICS trial expected to be fully enrolled by end of Q2 2017. REPORTING OF TOP-LINE DATA ANTICIPATED IN Q1 2018. INITIATION OF A SECOND PHASE 3 CLINICAL TRIAL (:LOGICS) FOR COR-003 WITH EXPECTED REPORTING OF TOP-LINE DATA IN 2018. REVENUE GENERATING STARTING IN Q2 2017 6:11 AM HEALTHEQUITY REPEATS FY17 EPS AND REVENUE GUIDANCE IN SLIDE PRESENTATION ( HQY ). Co repeats guidance for FY17 (Jan), sees EPS of 0.38-0.42 may not compare to 0.51 Capital IQ Consensus Estimate sees FY17 (Jan) revs of 174-178 mln vs. 177.31 mln Capital IQ Consensus Estimate sees adjusted EBITDA of 59-62 mln co reported 671 network partners. 6:06 am Kona Grill sees Q4 revs below consensus Q4 comps -4.1 ( KONA ). Co issues downside guidance for Q4 (Dec), sees Q4 (Dec) revs of 43.6 mln vs. 45.72 mln Capital IQ Consensus Estimate. Same-store sales decreased 4.1 compared to an increase of 3.2 in the fourth quarter of 2015. quotSimilar to many of our restaurant peers, same-store sales for the fourth quartER WERE WEAKER THAN WE HAD ANTICIPATED AS WE TOO DID NOT EXPERIENCE A POST-ELECTION DAY SALES BOUNCE. WEAK RETAIL TRAFFIC, INCLEMENT WEATHER AND AN INFLUX OF NEW COMPETITION AS WELL AS CONTINUED WEAKNESS IN OIL-IMPACTED MARKETS CONTRIBUTED TO THE SOFT SALES. IN ADDITION, WE CYCLED OVER OUR MOST DIFFICULT QUARTERLY COMPARISON OF 2016 WHICH MADE ACHIEVING POSITIVE SAME-STORE SALES EVEN MORE CHALLENGING. quot 6:04 am Del Friscos Restaurant OFFERS PRELIM Q4 RESULTS AHEAD OF PRESENTATION AT 19TH ANNUAL ICR CONFERENCE ( DFRG ). Co sees Q4 revs 119-119.2 mln vs 117.45 mln Capital IQ CONSENSUS ESTIMATE, COMPS 0.8 quotWe are pleased that all three concepts posted positive comparable restaurant sales for the quarter with positive traffic at both Del Friscos Grille and Sullivans Steakhouse despite a negative drag to total comparable sales of 1.1 due to restaurants in oil challenged markets. In 2017 we will have several initiatives underway to enhance our understanding of our consumer, drive top-line growth and improve flow-thru at our existing restaurants while limiting development. We firmly believe this approach will pay long-term dividends for the benefit of all shareholders and enable us to ramp up growth in 2018 and beyond with improved returns on invested capital. quotquotFor fiscal year 2017, we will be opening three restaurants including a Del FriscoS DOUBLE EAGLE STEAK HOUSE IN PLANO, TX AND DEL FRISCOS GRILLES IN DOWNTOWN NEW YORK CITY AND WESTWOOD, MA. quot 6:02 am Valeant Pharma announces positive results from a second confirmatory pivotal Phase 3 study to assess the safety and efficacy of IDP-118 lotion in the treatment of plaque psoriasis ( VRX ). Within the Phase 3 study of 203 adult subjects with moderate to severe psoriasis, IDP-118 showed statistical significance (p lt 0.001) to vehicle with a treatment success rate at 8 weeks of 35.76 to 6.98. The primary endpoint of the 12-week study (8 weeks of treatment followed by 4 weeks of follow-up) was achievement of a quotclearquot to quotalmost clearquot score and at least a 2 grade improvement based on aN INVESTIGATOR GLOBAL ASSESSMENT ( IGA ) at 8 weeks, and clear to almost clear and at least 2 grade improvement in the IGA at weeks 12, 6, 4 and 2 as secondary endpoints. 5:57 am SampP futures vs fair value: 1.80. Nasdaq futures vs fair value: 3.60. 5:57 am European Markets. FTSE. 7259.97. 22.20. 0,30. DAX. 11589.26. 25.30. 0,20. 5:57 am Mercados asiáticos. Nikkei. 19301. -152.90. -0.80. Hang Seng. 22745. 186.20. 0,80. 5:50 am NanoString Technologies receives positive assessment for NanoStrings Prosigna Blue Cross Blue Shield Association ( NSTG ) : Co announced that the Blue Cross Blue Shield Association Evidence Street has issued a positive assessment of the Prosigna Breast Cancer Gene Signature Assay. Evidence Street pioneered the development of scientific criteria for assessing medical technologies through comprehensive reviews of clinical evidence. The positive Evidence Street assessment is in line with updated ASCO guidelines released in February 2016. The ASCO guidelines recommend the use of the Prosigna Breast Cancer assay to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer with known hormone receptor and HER2 status. 5:47 am General Moly CFO to depart in May ( GMO ) : Co announced that effective May 12, 2017 Lee Shumway, Chief Financial Officer and Principal Accounting Officer, will depart from the Company. Shumway informed the Company last week that effective July 1, 2017 he quothas accepted the call from The Church of Jesus Christ of Latter-day Saints to serve as one of the Churchs international mission presidents. quotThrough mid-May, Shumway will continue with the Company in his current roles. 5:46 am Veolia Environnement awarded two platform decommissioning contracts for recycling ( VEOEY ). Veolia and its partner Peterson have been awarded two platform decommissioning contracts for recycling at their facility in Great Yarmouth, England. With an aim of reaching 96 recycling rates the work to recycle materials and assets is expected to begin in spring 2017 when the platforms arrive onshore. 5:43 am On The Wires (:WIRES). The Chemours Company (CC) announced it has entered into an agreement to sell The DuPont Building to The BucciniPollin Group, a privately held, full-service real estate acquisition, development, and management company. Shutterstock (SSTK) announced that it has expanded its milestone multi-year deal with The Associated Press. Beginning this week, Shutterstock will distribute APs daily global photo output for license to customers based in the United Kingdom. Shutterstocks enterprise customers in the United Kingdom will have access to over 30 million photos from AP Images. FTI Consulting (FCN) announced the appointment of Romain Bgramian as a Senior Managing Director in the Corporate Finance amp Restructuring segment in Paris. Amazon (AMZN) and Xilam Animation announced a multi-year content deal that makes Amazon Prime Video India the exclusive subscription streaming home of all four existing and three upcoMING SEASONS OF THE IMMENSELY POPULAR ANIMATED SERIES OGGY amp THE COCKROACHES AND ZIG amp SHARKO. CLEARINK DISPLAYS TODAY ANNOUNCED THAT THEY SIGNED A COMPREHENSIVE MATERIALS DEVELOPMENT AGREEMENT WITH MERCK KGAA (MKGAY) FOCUSED ON BRINGING CLEARINKS INNOVATIVE, PATENTED, REFLECTIVE DISPLAY TECHNOLOGY TO MARKET BY THE END OF 2017. FUJITSU LABORATORIES (FJTSY) HAS ANNOUNCED DEVELOPMENT OF THE WORLDS FIRST SLIDE-STYLE PALM VEIN AUTHENTICATION TECHNOLOGY. THIS TECHNOLOGY IS COMPACT ENOUGH TO BE EQUIPPED TO FUTURE TABLETS AND OTHER HANDHELD MOBILE DEVICES. AON PLC (AON) HAS LAUNCHED BREXIT NAVIGATOR, A BESPOKE AND PROPRIETARY THREE STEP SOLUTION DESIGNED TO HELP ORGANISATIONS QUANTIFY THE IMPACT OF BREXIT RISK EXPOSURES, AND REDESIGN RISK MANAGEMENT AND RISK FINANCING STRUCTURES. BREXIT NAVIGATOR IS SUPPORTED BY AN INTERACTIVE TOOL THAT PRESENTS SCENARIO-BASED INSIGHTS FOR EACH OF THE EU FOUR FREEDOMS: GOODS, CAPITAL, SERVICES AND PEOPLE, WHICH HELP ASSESS THE IMPACT OF BREXIT. SONY (SNE) PICTURES TELEVISION NETWORKS, ASIA ANNOUNCED A MULTI-YEAR AGREEMENT WITH FREMANTLEMEDIA INTERNATIONAL AND SYCO ENTERTAINMENT FOR THE RIGHTS TO ASIAS GOT TALENT, THE RECORD-BREAKING SERIES THAT PREMIERED FIRST ON SONYS AXN CHANNEL IN 2015. THE AGREEMENT FORMS PART OF SPT NETWORKS LONG TERM STRATEGY TO FURTHER BUILD ON ITS PIPELINE OF SUCCESSFUL ORIGINAL PRODUCTIONS. CHINA DIGITAL TV HOLDING CO (STV) ANNOUNCED THAT BEIJING CYBER CLOUD TECHNOLOGY CO, A SUBSIDIARY OF CHINA DIGITAL TV, ENTERED A CAPITAL INCREASE AGREEMENT WITH SHOUTAI JINXIN CAPITAL MANAGEMENT, A FUND MANAGEMENT COMPANY IN CHINA, PURSUANT TO WHICH SHOUTAI JINXIN WILL INVEST RMB33.0 MILLION IN CASH INTO CYBER CLOUD. 5:37 AM NANOSTRING TECHNOLOGIES SEES Q4 REVS BELOW CONSENSUS ( NSTG ). Co issues downside guidance for Q4 (DEC), SEES Q4 (DEC) REVS OF 24.2-25.7 MLN VS. 29.00 MLN CAPITAL IQ CONSENSUS ESTIMATE. AS SUCH, CO ISSUES downside guidance for FY16 (Dec), sees FY16 (Dec) REVS OF 85.5-87.0 MLN VS. 90.48 MLN CAPITAL IQ CONSENSUS ESTIMATE VERSUS PRIOR GUIDANCE OF 89.0-93.0 MLNOPERATIONAL HIGHLIGHTS: 140 NCOUNTER ANALYSIS SYSTEMS SOLD IN 2016, INCLUDING 60 NCOUNTER SPRINT PROFILERS INSTALLED BASE OF 480 NCOUNTER ANALYSIS SYSTEMS AT DECEMBER 31, 2016 MORE THAN 1,450 CUMULATIVE PEER-REVIEWED PUBLICATIONS OF STUDIES BASED ON NCOUNTER TECHNOLOGY AS OF DECEMBER 31, 2016 5:28 AM TAIWAN SEMI REPORTS DEC REVS OF NT78.1 BLN, UP 33.9 YOY REPORTS FY16 REVS ABOVE CONSENSUS ( TSM ). Co issues upside guidance for FY16 (Dec), sees FY16 (Dec) revs of NT947.9 bln vs. NT943.29 bln Capital IQ Consensus Estimate. 5:22 am Hecla Mining FY16 production silver 48 YoY Gold 24 YoY ( HL ) : Co reports preliminary silver and gold production results for the fourth quarter and full year 2016 that exceeded the Companys expectations. 2016 HIGHLIGHTS (compared to 2015) Silver production of 17.2 million ounces, a 48 increase. Gold production of 233,929 ounces, a 24 increase. Silver equivalent production of 46.1 million ounces, or gold equivalent production of more than 631,000 ounces, a 23 increase.2Lead production increased 6 and zinc production decreased 2. Cash, cash equivalents and short-term investments of approximately 198 million at December 31, 2016, an increase of about 43 million for the year. 4:43 am Royal Bank of Canada issues GBP500 mln of 1.125 Covered Bonds due 2021 ( RY ). 4:18 am Kite Pharma and Fosun Pharma establish JV in China to develop and commercialize autologous T-Cell Therapies Kite to Receive upfront payment of 40 mln ( KITE ) : Kite Pharma ( KITE ) and Shanghai Fosun Pharmaceutical announced a joint venture, FOSUN PHARMA KITE BIOTECHNOLOGY CO, TO DEVELOP, MANUFACTURE AND COMMERCIALIZE AXICABTAGENE CILOLEUCEL IN CHINA WITH THE OPTION TO INCLUDE ADDITIONAL PRODUCTS, INCLUDING TWO T CELL RECEPTOR PRODUCT CANDIDATES FROM KITE. AXICABTAGENE CILOLEUCEL, KITES LEAD PRODUCT CANDIDATE, IS AN INVESTIGATIONAL CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY UNDER DEVELOPMENT FOR THE TREATMENT OF B-CELL LYMPHOMAS AND LEUKEMIAS. THE JOINT VENTURE WILL BE REGISTERED IN SHANGHAI AND OWNED EQUALLY BETWEEN KITE PHARMA, A PIONEER IN THE FIELD OF ENGINEERED T-CELL THERAPY FOR CANCER, AND FOSUN PHARMA, A LEADING HEALTHCARE GROUP IN CHINA. UNDER THE TERMS OF THE AGREEMENT, FOSUN PHARMA WILL PROVIDE THE RMB EQUIVALENT OF 20 MILLION IN FUNDING TO SUPPORT CLINICAL DEVELOPMENT AND MANUFACTURING ACTIVITIES AND KITE WILL PROVIDE CERTAIN TECHNICAL TRANSFER SERVICES TO THE JOINT VENTURE. EACH PARTY WILL SHARE IN ANY PROFITS FROM THE JOINT VENTURE WITH KITE PHARMA RECEIVING 40 PERCENT AND FOSUN PHARMA RECEIVING 60 PERCENT. KITE WILL ALSO RECEIVE AN UPFRONT FEE OF 40 MILLION FROM THE JOINT VENTURE, FUNDED BY FOSUN PHARMA, REGULATORY AND COMMERCIAL MILESTONES TOTALING 35 MILLION AND MID-SINGLE DIGIT SALES ROYALTIES FOR AXICABTAGENE CILOLEUCEL. THE JOINT VENTURE WILL INITIALLY FOCUS ON AXICABTAGENE CILOLEUCEL, KITES LEAD CAR PRODUCT CANDIDATE FOR THE TREATMENT OF B-CELL LYMPHOMAS AND LEUKEMIAS. THE JOINT VENTURE WILL ALSO HAVE THE OPTION TO LICENSE ADDITIONAL PRODUCT CANDIDATES INCLUDING KITE-439, A TCR THERAPY DIRECTED AGAINST THE HUMAN PAPILLOMAVIRUS TYPE 16 E7 ONCOPROTEIN AND KITE-718, A TCR THERAPY DIRECTED AGAINST MAGE A3 AND MAGE A6, ANTIGENS FREQUENTLY FOUND IN SOLID TUMORS INCLUDING BLADDER, ESOPHAGEAL, HEAD AND NECK, LUNG AND OVARIAN CANCERS. OPT-IN AND MILESTONE PAYMENTS FOR KITE-439 AND KITE-718 COULD TOTAL 140 MILLION PLUS PROFIT SHARING AND MID-SINGLE DIGIT SALES ROYALTIES. 4:13 AM VALEANT PHARMA DIVESTS ITS CERAVE, ACNEFREE AND AMBI SKINCARE BRANDS TO LOREAL ( LRLCY ) for 1.3 bln ( VRX ) : Valeant Pharmaceuticals ( VRX ) announced that it has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to LOral ( LRLCY ) for 1.3 bln in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of of 168 million. The CeraVe brand portfolio offers a range of advanced skincare products, including cleansers, moisturizers, sunscreens, healing ointments and a dedicated baby line. Developed with dermatologists, CeraVe is one of the fastest growing skincare brands in the U. S. with average growth over the past two years exceeding 20. The AcneFree brand portfolio offers a full range OTC cleansers and acne treatments in the U. S. introduced to the market in 1966. The AMBI brand portfolio offers a range of skincare products formulated for the needs of multicultural consumers that includes creams, cleansers and moisturizers in the face and body category. Valeant will use the proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility. The transaction is expected to close in the first quarter of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals. Wachtell, Lipton, Rosen amp Katz acted as advisor to Valeant on the transaction. 4:10 am On The Wires (:WIRES). PropTiger and Housing, two of Indias leading online real estate service providers, today announced they will come together to become Indias largest online real estate services company. AS PART OF THE TRANSACTION, REA GROUP WILL INVEST 50 MILLION IN THE JOINT ENTITY, WITH AN AFFILIATE OF SOFTBANK GROUP CORP, INVESTING 5 MILLION. NEWS (NWS, NWSA) REMAINS THE LARGEST SHAREHOLDER OF PROPTIGER, AND ALSO OWNS 61.6 OF REA GROUP. REPRESENTATIVES OF REA AND SOFTBANK (SFTBY) WILL JOIN THE BOARD OF THE JOINT ENTITY, WHICH WILL CONTINUE TO BE CHAIRED BY A NEWS CORP REPRESENTATIVE. GEMALTO (GTOMY) IS PARTNERING WITH BANMA TECHNOLOGIES CO FOR THE PRODUCTION OF CHINAS FIRST INTERNET CAR -- THE ROEWE RX5. BANMA IS A NEW JOINT VENTURE BETWEEN ALIBABA GROUP (BABA) AND SAIC MOTOR CORPORATION. CHINA MOBILE (CHL) AND NUAGE NETWORKS, THE NOKIA (NOK) VENTURE FOCUSED ON SOFTWARE-DEFINED NETWORKING SOLUTIONS TO BUILD A HIGHLY-RESPONSIVE SOLUTION THAT WILL SCALE TO MEET THE NEEDS OF A MASSIVE DEPLOYMENT OF APPROXIMATELY 2000 PUBLIC CLOUD SERVERS IN THE CITIES OF BEIJING AND GUANGZHOU. SDN SOLUTION WILL INCREASE SPEED OF DEPLOYMENTS BY TEN TIMES, WHILE REDUCING OPERATING EXPENSES BY UP TO 50 HUTCHISON CHINA MEDITECH (HCM) ANNOUNCES THAT IT HAS INITIATED A PHASE I TRIAL OF ITS NOVEL SPLEEN TYROSINE KINASE INHIBITOR, HMPL-523, IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN CHINA. THE FIRST PATIENT WAS DOSED ON DECEMBER 27, 2016. THIS STUDY COMPLEMENTS THE ONGOING PHASE I TRIAL IN PATIENTS IN AUSTRALIA WITH HEMATOLOGICAL MALIGNANCIES, WHICH IS EXPECTED TO COMPLETE DOSE-ESCALATION IN THE FIRST HALF OF 2017. BROCADE (BRCD) ANNOUNCED THAT FENG CHIA UNIVERSITY HAS SUCCESSFULLY DEPLOYED A NEW IP NETWORKING SOLUTION TO DELIVER SMART NETWORK ACCESS WITHIN ITS ON-CAMPUS STUDENT ACCOMMODATIONS. THE DECISION TO DEPLOY THE BROCADE SOLUTION REFLECTS THE STRENGTH OF ITS SOFTWARE-DEFINED NETWORKING CAPABILITIES, WHICH IS PART OF THE UNIVERSITYS STRATEGIC DIRECTION FOR ENABLING NEW NETWORK SERVICES. 4:02 AM HUANENG POWER REPORTS FY16 POWER GENERATION WITHIN CHINA DECLINED BY 2.1 YOY ( HNP ) : Co announced its power generation for the year of 2016. According to the preliminary statistics of the Company, for the fourth quarter of 2016, the Companys total power generation by its power plants within China amounted to 81.097 billion kWh on consolidated basis, representing an increase of 2.02 over the same period last year, and the total electricity sold by the Company amounted to 76.064 billion kWh, representing an increase of 1.57 over the same period last year. For the whole year of 2016, the Companys total power generation BY ITS POWER PLANTS WITHIN CHINA AMOUNTED TO 313.690 BILLION KWH ON CONSOLIDATED BASIS, REPRESENTING A DECREASE OF 2.13 OVER THE SAME PERIOD LAST YEAR, AND THE TOTAL ELECTRICITY SOLD BY THE COMPANY AMOUNTED TO 295.800 BILLION KWH, REPRESENTING A DECREASE OF 2.05 OVER THE SAME PERIOD LAST YEAR. FOR THE WHOLE YEAR OF 2016, THE COMPANYS AVERAGE ON-GRID ELECTRICITY SETTLEMENT PRICE FOR ITS POWER PLANTS WITHIN CHINA AMOUNTED TO RMB396.60 PER MWH, REPRESENTING A DECREASE OF 10.53 OVER THE SAME PERIOD LAST YEAR. FOR THE FOURTH QUARTER OF 2016, THE POWER GENERATION OF TUAS POWER LIMITED IN SINGAPORE, WHICH IS WHOLLY-OWNED BY THE COMPANY, ACCOUNTED FOR A MARKET SHARE OF 21.4 IN SINGAPORE, REPRESENTING AN INCREASE OF 0.1 PERCENTAGE POINT COMPARED TO THE SAME PERIOD OF LAST YEAR. FOR THE WHOLE YEAR OF 2016, ITS ACCUMULATED POWER GENERATION ACCOUNTED FOR A MARKET SHARE OF 21.5 IN SINGAPORE, REPRESENTING A DECREASE OF 0.2 PERCENTAGE POINT COMPARED TO THE SAME PERIOD OF LAST YEAR. 3:57 AM WILLIAMS COS PRICES 65 MLN SHARES OF COMMON STOCK AT 29.00 PER SHARE ( WMB ). 3:56 am Valeant Pharma to divest Dendreon for 819.9 mln ( VRX ) : Co announces it divests outstanding equity interests in Dendreon Pharmaceuticals to the Sanpower Group Co, one of the largest privately owned conglomerates in China. Under the terms of the transaction, Valeant will receive cash consideration of 819.9 million at completion. Dendreons first and only commercialized product is Provenge, an autologous cellular immunotherapy for prostate cancer treatment approved by the FDA in April 2010Valeant will use proceeds from the sale of Dendreon to permanently repay term loan debt under its Senior Secured Credit Facility. The transaction is expected to close in the first half of 2017, subject to customary closing conditions, including receipt of applicable regulatory approvals. 3:46 am Petrobras Brasileiro prices 4 bln in Global NOTES ( PBR ) : Co prices terms of the following: 2 bln of 6.125 Global Notes due 2022 2 bln of 7.375 Global Notes due 2027 3:25 am Pacific Continental to be acquired by Columbia Banking System ( COLB ) for 27.85 per share expected to be immediately accretive to Columbias earnings per share ( PCBK ) : Columbia Banking System ( COLB ) and Pacific Continental ( PCBK ) jointly announced the signing of a definitive agreement to merge Pacific Continental into Columbia in a transaction valued at 644.1 million, or 27.85 per share based on Columbias January 9, 2017 stock price. The combined company will have 12 billion in assets with over 150 branches throughout Washington, Oregon and Idaho. Pacific Continental shareholders are entitled to receive 0.6430 of a share of Columbia common stock for each share of Pacific Continental stock, subject to certain potential adjustments. Based on Columbias closing stock price as of January 9, 2017, the aggregate merger consideration is valued at 644.1 million, or 27.85 per share, which includes 629.5 million of Columbia stock to be issued to Pacific Continental shareholders and 14.6 million of cash to be issued to the holders of options, stock appreciation rights and restricted stock units. The value of the merger consideration will fluctuate until closing based on the value of Columbias stock and subject to a capcollar. At CLOSING, PACIFIC CONTINENTAL SHAREHOLDERS WILL OWN APPROXIMATELY 20.0 OF THE COMBINED COMPANY. THE ACQUISITION IS EXPECTED TO CLOSE IN MID-2017 AND TO BE IMMEDIATELY ACCRETIVE TO COLUMBIAS EARNINGS PER SHARE WITH 8 AND 10 PROJECTED ACCRETION IN 2018 AND 2019, RESPECTIVELY. THE TANGIBLE BOOK VALUE EARNBACK IS 3:22 AM YAMANA GOLD PROVIDES UPDATE ON LABOUR NEGOTIATIONS IN CHILE COLLECTIVE BARGAINING AGREEMENTS HAVE BEEN ENTERED ( AUY ) : Co provides an update relating to negotiations with unions at its mines in Chile. As part of the collective bargaining renewal process, tHE COMPANY HAS BEEN IN NEGOTIATIONS WITH UNIONS REPRESENTING WORKERS EMPLOYED AT EL PENON AND MINERA FLORIDA. COLLECTIVE BARGAINING AGREEMENTS HAVE BEEN ENTERED INTO AT MINERA FLORIDA, AND THE MINE AND PLANT ARE OPERATING AT FULL CAPACITY. IN RELATION TO EL PENON, THE COMPANY HAS SUCCESSFULLY ENTERED INTO A COLLECTIVE BARGAINING AGREEMENT WITH THE UNION REPRESENTING SUPERVISORS AND HAS TABLED A FINAL OFFER TO THE TWO UNIONS REPRESENTING UNDERGROUND WORKERS. THE FINAL OFFER TOOK INTO CONSIDERATION THE CURRENT COMMODITY PRICE ENVIRONMENT AND THE ONGOING EVALUATION OF THE OPTIMAL LONG-TERM PRODUCTION AND COST PROFILE AT EL PENON, ALONG WITH SEVERAL OTHER FACTORS INCLUDING RECENT COLLECTIVE BARGAINING SETTLEMENTS AT OTHER MINES IN COUNTRY INCLUDING AT MINERA FLORIDA AND AT EL PENON WITH THE SUPERVISORS. BOTH UNIONS REPRESENTING UNDERGROUND WORKERS HAVE REJECTED THE COMPANYS FINAL OFFER WITH ONE UNION ON STRIKE AND THE OTHER NOW IN A STRIKE POSITION AND EXPECTED TO STRIKE. THE COMPANY CONTINUES TO WORK WITH LOCAL AUTHORITIES AND LABOUR MINISTRY REPRESENTATIVES TO ENSURE IT PRESERVES ITS LEGAL REMEDIES AND OPTIONS INCLUDING IMPOSING A PARTIAL OR TOTAL LOCKOUT AND WITH UNION REPRESENTATIVES TO DETERMINE ANY REASONABLE RESOLUTION OF THE COLLECTIVE BARGAINING PROCESS. 3:20 AM AKERS BIOSCIENCES PRICES 1,667,000 SHARES OF COMMON STOCK AT 1.20 PER SHARE, TOGETHER WITH 833,500 FIVE-YEAR WARRANTS TO PURCHASE COMMON STOCK WITH AN EXERCISE PRICE OF 1.50 ( AKER ). 3:06 am Rent-A-Center CEO resigns Chairman appointed as interim CEO ( RCII ) : Co announced the resignation of Robert D. Davis as Chief Executive Officer and director effective immediately. Board Chairman Mark E. Speese, the Companys founder and former chief executive officer, will serve as interim CEO of the Company until a permanent successor has been named. The Board of Directors announced that it will conduct a search process to find a highly qualified candidate for CEO. 3:05 am Allegiant Travel reports Dec Traffic RPMs rise 10.3 YoY ( ALGT ) : Co reports Total System Passengers rose 15 YoY to 974,319 Revenue passenger miles (000) 888,443 10.3Available seat miles (000) 1,127,454 13.8Load Factor 78.8 (2.5 pts)Departures 7660 21.1 Guidance: January 2017 Scheduled Departures: 20 ASMs: 16
No comments:
Post a Comment